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A note on abbreviations 
The abbreviation "ED" is used throughout the text to stand for 
"Emergency Department". In some interviews, patients refer to the "ER", 
or Emergency Room, as the Emergency Department was previously 
known. 
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I. Introduction 
Sickle-cell disease presents a unique set of problems for the patient- 
physician relationship. From the patient’s standpoint, sickle-cell disease 
represents a life-long, disabling chronic disease, which can lead to many 
psychosocial difficulties and dependence on analgesic medications. From 
the physician’s standpoint, the disease represents a profound failure of 
modern medicine: despite exquisite understanding of the pathological 
basis of the disease in abnormal hemoglobin, no treatment has yet been 
found to substantially ameliorate the suffering caused by the disease, nor 
to halt progression of the disease in most cases. In addition, no objective 
method of diagnosing painful crisis yet exists, which places diagnosis 
largely in the subjective realm. 
These inherent difficulties in the patient-physician relationship are 
exaggerated in the modern Emergency Department, in which a large 
volume of patients with increasingly acute illness burdens both physicians 
and patients. Furthermore, Emergency Departments are increasingly taxed 
as they become the means by which many patients seek primary care for 
relatively less acute illness. In this environment, patients who return 
repeatedly, requesting pain medications but not responding over the long 
term to any known treatment, run the risk of arousing suspicions of drug 
dependence or drug-seeking among Emergency Department staff and 
house officers. For the patient, the Emergency Department, especially in a 
teaching hospital, is an often chaotic place in which treatment is likely to 
be given by previously unfamiliar physicians. 
One may hypothesize that in such an environment, a circle of 
suspicion and frustration may develop. This theoretical circle might begin 
with a small subset of sickle-cell patients whose disease has especially 
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severe manifestations, and who seek care frequently in the Emergency 
Department. Some of these patients may become well known to 
Emergency Department staff as requiring frequent and high doses of 
narcotic analgesics. Irrespective of the actual prevalence of drug 
dependence among patients, suspicions of drug dependence may arise, 
leading to a tendency among Emergency Department physicians to limit 
the prescription of narcotic analgesics to sickle-cell patients in general. 
Thus, many sickle-cell patients in crisis may receive less than the quantity 
of narcotic analgesics necessary to control their crisis pain. In such a 
situation, their requests for additional pain medication may lead to 
escalating suspicions of drug-seeking among ED staff and increased 
limitations on prescription of narcotics. In this way a circle of suspicion 
and frustration may begin to fuel itself. 
The present study aims to investigate this hypothetical circle at 
several points, and to gather the information necessary to organize 
management interventions to interrupt it. To this end, the study will be 
arranged in three parts: 1) a literature review, 2) an analysis of hospital 
visits and admissions to YNHH during the period of a year, and 3) 
interviews with a subgroup of patients who were the most frequent visitors 
to the Emergency Department during the study year. In the discussion 
section, a number of possible interventions will be discussed in light of the 
results of the study. 
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II. Literature Review 
The difficulties of treating patients with sickle-cell disease have been 
intensively studied ever since Herrick first definitively described the 
manifestations of the disease in 1910. In this section, therefore, an 
overview of the literature on sickle-cell disease will be given, concentrating 
on factors which influence the interaction between the patient with sickle¬ 
cell disease and his or her health care providers. 
This section will begin with a general discussion of the various 
attempts by modern medicine to understand and treat sickle-cell disease. 
After all, the relationship between doctor and patient in sickle-cell disease 
has been conditioned to date by the intractability of the disease to all but 
symptomatic treatment. In addition, modern medicine’s efforts to 
objectively confirm the presence of sickle-cell crisis will be reviewed. 
These efforts have been in three general areas: laboratory tests, physical 
examination, and psychological testing. 
Next, the literature on the doctor-patient relationship in general will 
be briefly reviewed, with emphasis on the nature of the "sick role" assumed 
by many patients with chronic disease. In particular, "Social Labelling 
Theory", an area which concerns itself with the way in which medical 
judgements or diagnoses in themselves affect patients’ lives and social 
interactions, will be discussed. 
Literature on psychological aspects of sickle-cell disease, especially as 
regards the effects of chronic disease and pain on patients with sickle-cell 
disease, will be reviewed in some detail. Special emphasis will be placed 
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on "secondary gain" and adversarial relationships with health-care 
providers. 
Finally, pain control during sickle-cell vaso-occlusive crisis will also 
be reviewed, concentrating on the role of narcotic analgesics and non¬ 
steroidal anti-inflammatory medications in sickle-cell disease. 
A. Medical issues: 
1. Frustration in treatment since discovery of the disease 
a. Historical issues 
A look at the history of sickle-cell disease in modern medicine 
reveals a good deal about the frustration felt by clinicians working with 
this disease every day. After all, though it is a history of triumphs in 
understanding the molecular basis of the disease, attempted treatments for 
the disease have been either toxic or ineffective. Therefore, this section 
will begin with a brief discussion of the discovery of the pathogenesis of 
the disease. ('). 
Though syndromes now identifiable as sickle-cell disease had been 
recognized by African peoples for many years previously (2), the disease 
was first described to Western medicine by James B. Herrick, at a 
conference. His full report was published in the Annals of Internal 
Medicine in 1910 (3). Herrick’s investigation had begun some six years > 
( 
_ i 
1 The review of this subject by Conley is the most extensive one available, see ConIey,x 
1980 
2 see the reports of Felix Konotey-Ahulu. cited in Conley, p. 319 
3 Herrick, 1910 
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earlier, during an examination of the blood from an anemic student from 
the West Indies. After Herrick’s initial report, the clinical pattern was 
established slowly, as case reports appeared over the next several decades. 
In 1927 Hahn and Gillespie reported that sickling of the red cells 
occurs when hemoglobin is deoxygenated, a great leap forward in 
understanding the pathogenesis of the disease: "It is reasonable to suppose 
that sickle cells are formed in the body of an affected person wherever the 
oxygen tension and hydrogen ion concentration are such as to render the 
distorted form of the corpuscles stable" (4). In 1933, L.W. Diggs presented 
a remarkably complete description of the lesions seen at autopsy in a large 
group of patients with sickle-cell anemia, and suggested a mechanism for 
his observations: "A possible explanation of the capillary engorgement is 
that the elongated and spiked cells interlock and pass with more difficulty 
through narrow spaces than do normal cells." (5) 
A tremendous breakthrough in the understanding of the sickling 
process came during a conversation between William B. Castle and Linus 
Pauling, on a train ride from Denver to Chicago in 1945. Pauling recalls 
that Castle, in mentioning the birefringence of deoxygenated, sickled red 
blood cells seen with polarized light, suggested that sickle cells might 
"contain an abnormal kind of hemoglobin, which when deoxygenated has 
the power of combining with itself into long rigid rods, which then twist 
the red cell out of shape" (6). Pauling began to work on the problem with 
his graduate students, and in 1949 he described the altered electrophoretic 
4 Hahn, 1927 
s Diggs, 1934 
6 Pauling, 1955. Note that Castle is modest in his own account of the same 
conversation: "I am equally clear that I did not make the further generalization that 
it was orientation of the hemoglobin that might be doing this [ie. causing 
birefringence]" in Conley, p.339 
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mobility of the hemoglobin of patients with sickle-cell anemia, and 
ascribed the change to an alteration in the globin. With electrophoresis, 
the group was able to prove that the red blood cells of those with sickle 
cell "trait" contained both normal and sickle hemoglobin. Thus it was 
proven that the person with sickle-cell trait was a heterozygous carrier of 
the sickling gene. 
It was in 1956 that Vernon Ingram combined electrophoresis and 
chromatography in examining tryptic fragments of sickle hemoglobin, to 
show that the abnormality lay in a single peptide. (7). In the years 
following this discovery there was a tremendous burst of research into the 
structure of hemoglobin, and by 1961 the entire primary structure of 
hemoglobin had been elucidated. Thus it was discovered that the site of 
the amino acid replacement in sickle hemoglobin is at the sixth residue of 
the beta chain. As Conley puts it, the "first molecular disease" had been 
discovered (8). After this, successes came quickly with the elucidation of 
the position of the aberrant residue on the surface of sickle hemoglobin, 
and with insights into deformation of the cell membrane by polymerized 
sickle hemoglobin. 
7 Ingram, 1958 
8 Conley p. 346 
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b. Clinical manifestations of siekle-cell disease 
The investigation of sickle-cell disease is made more difficult by the 
protean forms which sickle-cell disease may take in the individual patient. 
In addition, different clinical syndromes are experienced by patients with 
different combinations of the genes responsible for sickle-cell disease. 
Patients who are heterozygous for the sickle gene (AS) possess one 
copy of the sickle gene and one copy of the gene for "normal" hemoglobin 
A. These individuals are said to have sickle-cell "trait", and generally 
experience minimal clinical problems. Their overall life expectancy and 
rate of hospitalization is the same as those of individuals homozygous for 
hemoglobin A. Because their red blood cells contain enough hemoglobin 
A to prevent sickling under most circumstances, they experience sickle-cell 
crisis only when extremely dehydrated or hypoxic. Many patients with the 
AS phenotype have impaired ability to concentrate urine, and a few have 
painless hematuria due to infarction of the renal medulla, which is 
especially vulnerable to sickling (9). 
Patients who are homozygous for the sickle gene (SS) make no 
hemoglobin A, and may experience an extremely wide range of clinical 
manifestations, from mild to life-threatening, and in a variety of organ 
systems. Starting from about six month of age (when fetal hemoglobin has 
diminished enough to allow sickling by sickle hemoglobin), children with 
sickle-cell disease have a general delay in growth and development, and an 
increased tendency to develop infections, especially those due to 
encapsulated bacteria such as pneumococcus. The function of the spleen, 
which would normally remove such pathogens from the circulation, is 
Bunn, 1987, p. 1519 9 
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increasingly impaired by microinfarcts (10), until by adulthood only a 
nubbin of fibrous tissue remains. 
Adults who are homozygous for sickle hemoglobin have a severe 
hemolytic anemia, with hematocrits in the 18 to 30 percent range. Mean 
red blood survival is 10 to 15 days, as compared to a normal survival of 
120 days. Because these patients are so dependent on ongoing production 
of red blood cells, any infection w'hich affects erythropoiesis, such as that 
of parvovirus, can result in aplastic anemia and a rapid drop in hematocrit. 
However, the most characteristic syndrome affecting patients with sickle¬ 
cell disease is the vaso-occlusive "painful crisis", which can attack various 
parts of the body, particularly the abdomen, chest and joints. About a 
third of painful crises are preceded by a viral or bacterial infection. 
Others appear to be precipitated by cold weather or by dehydration. 
The extremely wide range of manifestations and complications of 
vaso-occlusive crisis makes differential diagnosis difficult. It is often 
difficult, for example, to differentiate between abdominal sickle crisis and 
some other acute process such as biliary colic, appendicitis, or a perforated 
viscus. Patients with abdominal crisis normally have no rebound 
tenderness and normal bowel sounds, and if surgery is performed, no gross 
evidence of infarction or ischemia is usually found. When sickle crisis 
appears in the lung, it may either mimic, or be complicated by, 
pneumonitis or pulmonary infarction. Similarly, when sickle crisis occurs 
in the extremities, it may be complicated by osteomyelitis, or confused 
with gout or rheumatoid arthritis. Patients with sickle-cell disease may 
even present with cerebral manifestations such as stroke, seizure or coma. 
In fact, vaso-occlusive crisis may affect almost any organ system, 
particularly the lungs, kidneys, liver, skeleton, and skin. (n) 
10 
ii 
see Pearson, 1985, p.392 
See Bunn, 1987, p. 1520-21 

Literature Review Page 9 
Among the various other variants of sickle-cell disease, an especially 
important one occurs in patients who are doubly heterozygous for sickle 
hemoglobin and hemoglobin C ("SC disease"). These patients have a mild 
to moderate hemolytic anemia, and less frequent sickle crises. For 
unknown reasons, patients with SC disease are especially vulnerable to 
ocular complications, particularly proliferative retinopathy and retinal 
detachment, as well as hematuria from renal medullary infarcts, and 
avascular necrosis of the femoral head. 
The protean manifestations of sickle-cell disease complicate the 
doctor-patient relationship in a variety of ways. Clearly, the possible 
presence of such complications as osteomyelitis or pulmonary infarction 
can make for an extremely complex and expensive diagnostic workup, 
which may nevertheless be completely negative. The choice of whether to 
begin such a workup is very difficult, and may have to be based on 
subjective criteria such as the patient’s expressions of pain. In a patient 
suspected of simulating painful crisis in order to obtain pain medications, 
the diagnostic uncertainty is even greater. After all, even a patient who 
has shown irrefutable drug-seeking behavior in the past may still be at 
genuine risk for a fatal sequel of sickle-cell disease in the present instance. 
c. Various attempts at treatment. 
Treatment of sickle-cell disease has not been as spectacularly 
successful as research into its underlying causes. Herrick reported success 
with rest, nourishing food, administration of boric acid to leg ulcers, and 
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the use of iodide, arsenic, and thymol. (12). Other treatments in the first 
half of the century included splenectomy, liver diet, iron, blood transfusion 
and a wide variety of other measures, none of which proved to be more 
than transiently successful (13). 
As the pathophysiology of the painful crisis began to be understood, 
various attempts were made at prophylaxis. The reader is referred to 
reviews by Charache and Conley (14) for a more detailed discussion of 
these attempts at prophylaxis. Some successes were achieved, as, for 
example, with partial exchange transfusions, which are still used to the 
present day. However, because of side effects such as long-term iron 
overload and the development of alloantibodies, the use of exchange 
transfusion is limited to preparation for surgery and other stressful 
situations, or the prevention of recurrent strokes. Similarly, oxygen was 
found to be somewhat effective, but carried the danger of depression of 
erythropoiesis and increased anemia (1S). 
Most of these attempts at treatment, however, were total failures, 
some of them spectacularly so. Nitrites and Carbon monoxide, for 
example, were used in the hope that sickling could be prevented by the 
resulting metnemoglobin and carboxyhemoglobin, but these treatments 
could not be safely administered. Also tried were sodium bicarbonate and 
sodium citrate, in the hope that increased pH would decrease sickling, but 
could not be shown to be effective in controlled trials. Urea and Cyanate 
as potential anti-sickling agents both generated tremendous excitement in 
laboratories across the country, but proved to be either ineffective, toxic. 
Herrick, 1910 
Charache, 1974 
Charache, 1974, pp. 698-705, and Conley, pp. 356-358 
Charache, 1981, p. 195-196 15 
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or both. Cyanate, in particular, caused a severe peripheral neuropathy, as 
well as cataracts. 
Even at present, treatments in use for sickle-cell disease do not 
attempt to modify sickle hemoglobin at all. but rather, attempt to 
ameliorate symptoms by causing an increase in production of fetal 
hemoglobin (t6). For example, some elevation of fetal hemoglobin has 
been achieved with the hematopoietic hormone erythropoietin, though the 
most recent study on its effects did not show any significant benefit (17). 
in addition, numerous cytotoxic drugs are known to increase production of 
fetal hemoglobin. For example, it has been shown that 5-azacytidine could 
stimulate dormant gamma globin genes in adults with sickle-cell disease, 
thereby increasing production of fetal hemoglobin. Similarly, in several 
studies with small patient samples, hydroxyurea has been shown to be 
effective in causing elevated levels of fetal hemoglobin over long periods 
with minimal toxicity, and with decrease in painful crises (18). However, 
none of these therapies has been yet shown to do more than reduce 
somewhat the frequency of painful crises; no known therapy can yet 
reduce the severity of crisis when it does occur. At present, medications 
such as hydroxyurea are considered experimental (19). 
Platt, 1988 
See Goldberg, 1990. Goldberg et als' trial examined the effects of ervthropoitin 
alone and with hydroxyurea in 5 patients. 
Charache, 1987. Recently Goldberg et al (1990) have achieved success in 5 
patients in increasing fetal hemoglobin and decreasing the rate of hemolysis in 
sickle-cell disease. Their trial of hydroxyurea also included erythropoietin, which 
was not found to be beneficial. 
Ironically, one of the most important medications in use against sickle-cell 
disease, namely, penicillin, does not even affect sickle cell crises, but rather 
protects against infections of pneumococcal and other encapsulated bacteria in 
sickle-cell patients with decreased splenic function; that is, it "compensates for 
the splenic paralysis sickling causes”. See Platt, 1988, p. 1479 
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Thus, though promising treatments are on the horizon, treatment of 
sickle-cell anemia remains at present about where it has been for decades, 
with the mainstays of medical treatment being analgesia, oxygen, and 
intravenous fluids (20). 
d. Programs to screen for Sickle-Cell Disease 
Given the failure of any medical therapy so far to significantly alter 
the course of sickle-cell disease, it is not surprising that various attempts 
have been made to reduce transmission of the sickle gene. In fact, a 
number of mandatory screening programs for newborns and adults were 
begun in the early 1970’s, in the hope that genetic counseling of carriers of 
the sickle gene would be effective in reducing the incidence of the disease 
(21). However, most of these programs were poorly organized, and for 
the most part offered little counselling or follow-up to people identified as 
carrying the sickle gene. Moreover, since prenatal diagnosis of the disease 
was not available at the time, "prevention" meant advising affected blacks 
not to have children, and was seen as having racist motivations (22). 
Within a iew years, mandatory testing of black patients was on the wane. 
Charache, 1974 and 1981, Platt 1988 
President’s Commission, 1983, p. 21-22, and Stamatoyannopoulos, 1974, p.271 
Robinson, 1973, p. 324. Also note that the use of penicillin as long-term 
prophylaxis against encapsulated organisms in children did not begin on a wide 
scale until Gaston’s report in 1986. See Platt, 1988. 
22 
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Lack of ability to verify sickle crises 
Another area of intense research has been the search for an objective 
test to confirm the presence of vaso-occlusive crisis. Considering the many 
neurological, hematological and psychological factors which may influence 
the pain of vaso-occlusive crisis, as well as the many medical 
manifestations of crisis, it is not surprising that no test has been found 
which is both sufficiently sensitive and sufficiently specific for routine 
clinical use (23). There are three general areas in which research has 
attempted to objectively differentiate the pain of "genuine" vaso-occlusive 
crisis from "non-organic" pain, namely, laboratory examination, physical 
examination, and psychological examination. 
a. Laboratory tests for Vaso-occlusive Crisis 
Put briefly, there is no laboratory test to verify the occurrence of 
sickle-cell vaso-occlusive crisis. However, several recent attempts have 
been made. For example, Brownell has described the use of serum ferritin 
levels as an indicator of sickle-cell crisis (24). The most obvious difficulty 
with this approach is that, as an acute-phase reactant, ferritin levels rise in 
a wide variety of circumstances. In an attempt to overcome the limitations 
in specificity of laboratory tests taken singly, several writers have 
employed combinations of measurements to confirm sickle-cell crisis. For 
example, increases in percentages of dense cells, erythrocyte sedimentation 
rate, fibrinogen levels. Magnetic Resonance Imaging and serum 
prostanoids have all been used, in various combinations, to verify sickle- 
Shapiro, 1989, p. 1031. Note also that it is still unclear what determines severity 
of the disease in a given patient - on this topic see Schechter, 1982 
24 Brownell, 1986 
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cell crisis (25). None of these has been successful, and none is routinely 
used in clinical practice. 
b. Physical Examination for Vaso-occlusive Crisis 
Clinical methods to objectively distinguish "genuine" vaso-occlusive 
crisis from "non-organic" pain have not been described specifically for use 
in sickle-cell disease. The discernment of the organicity or non-organicity 
of pain by physical examination would typically be considered in the realm 
of "clinical intuition" (26). For example, "It is widely thought that pain 
that never fluctuates in intensity of pain in a nonanatomic distribution 
suggests the involvement of psychologic or learning processes" (27). 
However, hard evidence for such views is lacking. 
Work to clarify this issue has been done in the case of low back pain, 
by Waddell. In his 1980 study, Waddell (2S) did not directly address the 
issue of "organicity", but rather tested the ability of various findings in the 
physical examination to predict the response of a patient with low back 
pain to physical treatments or surgery. For example, the examiner may try 
1) rolling the skin of the patient over the lumbar spine, or 
Lawrence, 1987 and Mankad, 1987 
Bonica, 1990, p. 1457 
Bonica. 1990, p. 597-98 
Waddell, 1980 28 
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2) lightly placing one’s hand on the patient’s head or rotating 
the patient’s upper body (shoulders and hips together). 
Since none of these maneuvers increase pressure in the lumbar spine, 
complaints of pain by the patient on these maneuvers raise the suspicion 
that the pain cannot be ascribed to a structural lesion in the spine. Other 
findings include 
3) a significant discrepancy in pain between straight leg 
raising in the seated and supine positions, 
4) non-physiological regional disturbances of sensation, 
distribution of pain, or weakness, and 
5) over-reaction to the test stimulus, with excessive 
verbalization, grimacing, or other "excessive" pain 
behaviors. 
Waddell showed that those patients with three or more positive 
findings rarely responded to any physical treatment or to surgery. It is 
important to remember, as Bonica points out, that "these are not tests of 
malingering; they only indicate that the patient's pain behaviors cannot be 
ascribed solely to structural lesions of the spine" (29). 
The situation in sickle-cell disease is different than that of low back 
pain in several respects. First, the pain of vaso-occlusive crisis may occur 
in almost any area of the body, making specific "positive" findings on 
physical examination difficult to describe. Second, in sickle-cell disease 
there is no modality (as, for example, surgery in some kinds of low back 
29 Bonica, 1990, p. 1458 
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pain) successful enough in treating the underlying disease that patients’ 
response to it could be correlated with given findings on physical exam. 
c. "Objective" Psychological tests 
Many attempts have been made to employ supposedly "objective" 
psychological testing to identify those patients who are prone to "non- 
organic” pain. For example, elevations in several subscales of the 
Minnesota Multiphasic Personality Inventory, especially Hypochondriasis, 
Depression, and Hysteria, have been noted in chronic pain patients (30). 
These scores have been interpreted to mean that chronic pain patients are 
characteristically preoccupied with their illness, unhappy, lacking in 
psychologic insight, and tending to develop somatic symptoms in response 
to stress and conflict (31). However, no single, pathognomonic pattern is 
observed on MMPI among patients with chronic pain, nor, of course, can it 
be established which, if any, of the chronic pin patients has an organic 
cause for the pain. 
A number of "objective" psychological indicators have been used to 
assess psychological factors in sickle-cell disease, but none has been 
successful in predicting clinical features of the disease in a given patient, 
nor in characterizing "genuine" vaso-occlusive crisis. Psychological testing 
of patients with sickle-cell disease will be discussed under "Psychology" 
below. 
30 
31 
Fordyce, 1976 
Bonica, 1990, p. 602 
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So far, we have reviewed the three main areas in which research has 
attempted to objectively verify the presence of vaso-occlusive crisis - in 
the laboratory, the examination room, and the psychologist's office. The 
failure of these efforts has a profound effect on the doctor-patient 
relationship, since it means that physicians cannot objectively differentiate 
"true" sickle-cell crisis pain from pain of other causes, including factitious 
pain in the context of drug-seeking. As with other conditions in which the 
principle complaint is chronic pain, there is no "gold standard" for proving 
"genuine" sickle-cell vaso-occlusive crisis. 
The literature on "objective" verification of pain often phrases the 
problem in terms of the patient, that is, it attempts to identify patients 
whose pain is non-organic. Waddell’s system for identifying patients who 
will not benefit from surgery is one example. However, such an approach 
applied to patients with sickle-cell disease may give misleading results, 
because the same patient who may fabricate the symptoms of a sickle-cell 
crisis one week may have a "genuine" crisis the following week. In other 
words, both "untrue" and "true" crises may occur at different times in the 
same patient. Therefore, the "validity" of sickle-cell pain must be judged 
anew for each sickle-cell crisis. 
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B. The Doctor-patient relationship in Sickle-cell Disease: 
1. General considerations 
The patient with sickle-cell disease seeking care in the Emergency 
Department of Yale-New Haven Hospital faces a large system developed 
to evaluate and treat efficiently a great number of patients. Consequently, 
the relationship between individual doctor and patient must be viewed in 
terms of its position within that larger system. Therefore, it will be useful 
to discuss the work of David Mechanic, who has examined the effects of 
the "bureaucratization" of medical care in large medical institutions. 
Mechanic points out the inherent conflict in the Emergency 
Department situation between the need to be efficient and the desire to 
provide care for patients’ social and emotional needs (32). Bureaucracy, 
after all, "encourages specialized activity, routinized procedures and modes 
of operation, [...] and there is a strong tendency for bureaucracies to try to 
limit client control." (33) In addition, as medical institutions become 
larger and more impersonal, a variety of intermediaries become interposed 
between the patient and the professionals who control their care. In fact, 
patients may even have difficulty ascertaining who is actually responsible 
for their care (34). Thus patients may feel that they are facing an 
impersonal system that does not understand their individual problems or 
pain. 
32 
33 
34 
Mechanic, p. 414 
Mechanic, p. 416 
Mechanic, p. 416 
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Conversely, Mechanic points out that within a bureaucratically 
organized medical system, physicians may feel equally frustrated. A 
special source of difficulty for the physician is the "patient with a high 
inclination to use medical care" (35) but no objectively verifiable basis for 
his or her symptoms: 
"There is no end to the depth of exploration that is theoretically 
possible, and the dc +or knows that he must live with the fact 
that it can never really prove that there is no underlying 
physical basis. [...] At some point he must begin to consider the 
risks of continued exploration: the dangers of the various 
diagnostic procedures, the economic costs of continued 
searching, and the probability that continued searching may 
reinforce the attitude of the patient that he is indeed physically 
Mechanic points out that physicians may in many cases feel that the 
treatment they provide may have at best a problematic value for their 
patients. Certain patients may develop an overdependence on physicians, 
and may actually be "adversely affected by particular kinds of intensive 
care and attention". (37). For example, "excessive focus on symptoms and 
life difficulties may reinforce an already hypochondriacal pattern, induce 
or encourage further displays of illness behavior, and bring about reduced 
coping effectiveness." (3S). In addition, such patients may be thought to 
be exploiting the "sick role", with its exemption from social responsibilities 
Mechanic p.426 
Mechanic p.426 
Mechanic, p. 431 
Mechanic p. 431 38 
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and obligations (39). Physicians may thus suspect that this exemption 
from responsibilities is one more aspect of the "secondary gain" patients 
may derive from their illness. 
2. The "Social labelling" Perspective on Illness 
In studying the treatment of patients with sickle-cell disease, it is 
essential to remember that most patients with the disease come in with the 
diagnosis of sickle-cell disease, and that physicians will bear this in mind in 
all subsequent medical decisions. In addition, the "illness label" of sickle¬ 
cell disease in itself can have profound effects on patients' lives, 
irrespective of the symptoms of the disease at any given time. In this 
context, it will be useful to discuss the sociological literature on "social 
labelling", which describes the way in which medical judgements or 
diagnoses in themselves affect patients’ lives and social interactions. 
An overview of "Social Labelling Theory" can be found in a 1981 
review by Nancy E. Waxier. She suggests that 
"A person is labelled as ’ill’ in the course of social negotiations 
between himself, his doctor, his family, and sometimes ward 
staff and others. The outcome of such social negotiations is 
influenced by each person’s beliefs and training and also by the 
social and organizational contexts in which the negotiation 
occurs. Once labelled as ’ill’, the individual may find himself 
caught in the midst of a self-fulfilling prophesy". I40) 
39 
40 
see esp. Parsons, 1951 
Waxier p. 85 
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Thus, for example, a diagnosis of mental retardation 'labels' a patient 
in the eyes of many as having a profound disability, and may profoundly 
change that person’s social relationships and future possibilities. However, 
as suggested in a 1973 study by Mercer, some parents, especially middle- 
class white parents, manage to "negotiate" another diagnosis to keep their 
children in normal classes, or simply send their children to a private or 
parochial school. Thus, the diagnosis of mental retardation ended up being 
disproportionately applied to black and hispanic students. (41) 
Similarly, individual patients may choose to adopt or discard a label 
of "illness", based not only on symptoms, but also on the patient’s social 
and economic background. A good example is found in a 1968 study, by 
Ludwig and Adams, of patient cooperation in a general rehabilitation 
center. It was found that among all physically disabled people in the 
program, the ones most likely to drop out before completion of the 
program, against physicians’ advice, were Caucasians, men, the middle 
aged, and those with previous employment. Conversely, those more likely 
to complete the program were blacks, women, the very old and very 
young, and the unemployed. Thus, the data appear to suggest that those 
who were in the most powerful social position, and those who had 
employment to return to, were most able to declare themselves "normal" 
by dropping out of the treatment system. On the other hand, those in a 
less powerful social position, and those with no employment, seem to have 
had more reason to continue (or less reason to discontinue?) their "sick 
role" in treatment. (42) 
41 
42 
Mercer, 1973 
Ludwig and Adams, 1968 
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Characteristics of the institution also influence the application of the 
label of "illness". For example, the desire of a given institution to admit a 
patient formally (and thereby substantiate the patient's "illness") may be 
determined by the number of beds available at the time. In a 1975 study, 
Harris found that increases in the number of hospital beds in 56 counties 
in New York State led to increases in the number of patients in the 
hospital, not because of any increased need, but because physicians 
responded to the new, empty beds by increasing admissions and 
lengthening hospital stays (43). Similarly, the financial situation of a 
hospital, and the expected reimbursement from the patient or his insurance 
company, may influence the decision whether the patient is "sick enough to 
be hospitalized" C44). A patient with no insurance, for example, might 
conceivably be less likely to be admitted than a patient with insurance for 
the same illness. 
The arguments of the "social labelling theory" can be applied in 
different senses to sickle-cell disease. Certainly, the presence or absence 
of sickle hemoglobin (hemoglobin S) is not "negotiated", and refutes the 
more extreme "social labelling theorists", who seem to imply that the 
labelling process "creates" the disease (45). In fact, the irrefutable 
presence of hemoglobin S in the red blood cells of patients with sickle-cell 
disease unavoidably conditions the entire interaction between an affected 
patient and his or her physician. 
However, the presence or absence of vaso-occlusive crisis is 
"negotiated" in a very real sense, since it is usually entirely subjective, 
experienced by the patient but not verifiable by the physician. It is in this 
sense that "social labelling theory" can be most easily applied. 
43 
44 
45 
Harris, 1975 
see Waxier, p. 93 
see Waxier, p.99,note 2 

Literature Review Page 23 
3. The "Gomer phenomenon" 
In this context, it is important to note that institutions may spawn a 
different, less formal sort of "label" for patients, not known to the patient, 
nor, for that matter, well known to the world outside the health care 
system. The term "GOMER" is a classic example, which is discussed in a 
1985 article by Leiderman and Grisso. This term may have a special 
relevance to the care of patients with sickle-cell disease, whose care 
presents many difficulties. 
First popularized in the novel House of God by Shem, "Gomers" 
appear as patients who frustrate the housestaffs every effort to ameliorate 
their condition. Leiderman and Grisso studied the way the term is used in 
an actual hospital by comparing a group of 18 "gomers" (as identified by 
housestaff) with a matched control group of "non-gomer" medical patients. 
In Leiderman and Grisso's study, the image of the "gomer" which 
emerges is not a simple stereotype: "Gomer is neither a class-linked nor 
race-linked pejorative term, nor is the term applied merely to malingering, 
self-destructive patients" (46). However, "gomers" distinguished 
themselves from medical patients in the control group by the special 
frustrations which their illnesses and management posed for resident 
physicians: "Gomers suffered irreversible mental deterioration; their 
illnesses were complex and intractable; they were unable to resume 
normal adult social roles; and they had no place to go after discharge" 
(47) 
46 
47 
Leiderman and Grisso, p. 294 
Leiderman and Grisso, 1985, p.294. See also p.290, table 2 
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Such patients have special importance to the reside t physician: 'The 
lingering presence on acute medical wards of patients for whom modern 
medicine can provide no therapy, or frequently even diagnosis, challenges 
physicians’ ideals about the powers of medicine" (48). in addition, 
"Gomers" rarely offer the resident physician an "interesting case", that is, 
one with educational value to the physician in training (49). Leiderman 
and Grisso suggest, however, that the situation may be different for the 
attending physician, who is "protected from the frustration, helplessness, 
and uncertainty that these patients generate". In fact, senior physicians 
have been known to severely censure housestaff for the use of epithets like 
"gomer" (50). 
Leiderman and Grisso’s article has the potential for application to 
patients with sickle-cell disease. With their multiple medical problems, 
sickle-cell patients require considerable effort by the housestaff, who are 
heavily involved in their care. Their illness is complex and intractable, and 
often is so disabling that normal adult social roles are impossible. 
Nevertheless, sickle-cell disease permits a relatively long life, and patients 
return again and again with frequently similar, inscrutable pain. As 
described above, few' therapeutic options are available beyond analgesia 
and hydration. Response to therapy is most often slow and incomplete. 
Neither are patients with sickle-cell disease often "interesting cases". In 
short, patients with sickle-cell disease fulfill many of the criteria for the 
role of "Gomer". 
Leiderman and Grisso, p. 294 
Leiderman and Grisso, p. 29S 
Leiderman and Grisso, p. 295 
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4. The "Undesirable Patient" 
In considering the nature of possible conflict between the patient 
with sickle-cell disease and his or her physician, it will be useful to have a 
framework for categorizing issues which lead to conflict. A useful article 
in this context was written in 1970 by Solomon Papper. He discusses the 
various types of "undesirability" which can make a patient unpleasant to his 
or her physician. (51) 
In Papper's scheme, qualities of patients "undesirable" to physicians 
can be broken down into five general groups: 
1) Socially undesirable: this category includes, for example, 
alcoholic, dirty, uneducated, very poor patients, as well as 
patients belonging to certain ethnic or religious groups. 
2) Attitudinally undesirable: for example, patients who "think they 
know too much", or who otherwise questions the physician's 
authority, or generally, those whose attitude frustrates the 
physician: 'The problem here is the patient’s lack of knowledge 
of, or failure to meet, the physician's expectations or needs" 
(52)- 
3) Undesirability on "physical" grounds: includes patients who lack 
a diagnosable physical illness or who do not respond to 
treatment (for example, "crocks"), and patients who have 
chronic (especially malignant) or simply "ordinary" (ie not 
"interesting") diseases. 
51 
52 
Papper, 1970. p.259 
Papper, p.260 
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4) Circumstantial undesirability: for example, the patient who 
arrives late, or on a busy clinic day. 
5) "Distraction" undesirability: for example, the patient who does 
not fulfill criteria for inclusion in the physician's research study, 
or who distracts him from his research. 
Papper's scheme will be helpful in considering the nuances of conflict 
between doctor and patient. In the case of sickle-cell disease, patients may 
fit into more than one category of "undesirability", as seen by their 
physicians. 
C. Psychological issues 
1. Introduction 
Psychological issues in the care of patients with sickle-cell disease are 
pivotal. After all, patients with sickle-cell disease are susceptible to all the 
difficulties of having a chronic, often painful, unpredictable disease with 
many ramifications for patients’ occupational and social lives. Therefore, 
in this section a brief overview will be given of the literature on 
psychological issues in sickle-cell disease. Then will follow a more detailed 
look at six leading articles on the subject, written from 1976 to 1989. 
The pain of sickle-cell vaso-occlusive crisis can be overwhelmingly 
stressful to patients. In fact, one writer, Barbara Shapiro, has compared the 
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intense, unpredictable pain of sickle-cell crisis to that experienced in the 
"learned helplessness" phenomenon in animals (53). 
For all the pain they experience, children do not seem to become 
seriously "psychosocially impaired". In fact, children with sickle-cell 
disease tested with various psycho-social instruments seem, with a few 
differences, to be remarkably similar to healthy children of similar age and 
socio-economic status (54). Evidence seems to indicate that difficulties in 
psychosocial functioning seem to increase during adolescence, especially in 
young males (55). 
Similarly, adolescence appears to be the time when adversarial 
relationships are most likely to develop between the patient with sickle-cell 
disease and his or her physicians and nurses (56). Puberty, difficult 
enough for healthy young people, may be especially difficult for both the 
patient and his health care providers. Barbara Shapiro, for example, has 
pointed out that adolescents with sickle cell disease must work through the 
usual developmental issues, which are marked by "intensive and often 
perplexing limit-seeking" (57). 
Shapiro, 1989, p. 1032 
Kumar, 1976, discussed below and Lemanek, 1986 
Leavell, 1983. discussed below, and Hurtig, 1986 
Vichinsky, 1982, discussed below 
Shapiro, 1989, p. 1033 57 
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Going to the hospital for treatment of sickle pain is a learned 
behavior, which is influenced by a number of variables, including the 
patient's age. experiences during previous hospitalizations, home 
environment and support, and economic situation (58). Thus, it is not 
surprising that there is wide variation patients’ propensity to use hospital 
services. Some patients are quick to visit a doctor at the onset of pain, 
while others attempt to manage even the most severe crisis at home. So, it 
is important to remember that the frequency of use of emergency services 
and the number of hospitalizations may not reflect the actual severity of a 
patient’s illness. 
Adults with sickle-cell disease appear to have a greatly increased 
prevalence of psychiatric and psychosocial impairment when compared to 
patients with otherwise similar socioeconomic status and severity of 
chronic illness, as discussed below (59). Patients with sickle-cell disease 
have been compared to patients with diabetes i60) and with asthma (61) 
(both discussed below). 
A more detailed discussion of six leading articles on psychological 
aspects of sickle-cell disease will now follow. 
Shapiro, 1989, p. 1033 
Damlouji, 1982 and Leavell, 1983, both discussed below 
Damlouji, 1982, discussed below 
Bobo, 1989, discussed below 61 
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2. Psychological issues: a more detailed look at six articles 
a. Kumar, 1976 
Santosh Kumar et al (62) studied a group of 29 adolescent children 
with sickle-cell disease, ages 12-18 years, selected apparently randomly 
from among patients making visits to the hematology clinic at the Los 
Angeles County/University of Southern California Medical Center (the 
article does not make clear how this sample was chosen). There was also 
a control group of 26 children drawn from a local high school, of the same 
age range and ethnic background. The subjects were given a battery of 
tests, including the "General Anxiety Scale for Children", the "Piers-Harris 
Self-Concept Scale", and the "California Test of Personality". 
Results of these tests indicated that patients with sickle-cell disease 
are 
"no different from the comparison group without sickle cell 
anemia on personal, social, and total adjustment scales. [...] 
The patients show significantly higher tendencies to withdraw 
(be lonely) than the comparison subjects on the personal 
adjustments. The patients also had significantly low'er social 
skills (liking for people, inconveniencing oneself to be of 
assistance to others, being diplomatic in one's dealing with both 
friends and strangers) than did normal subjects. The mean 
score for self-concept was significantly lower than that of the 
comparison group." (63) 
62 
63 
Kumar, 1976 
Kumar, p. 862 
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Interestingly, patients with sickle-cell disease scored lower on the anxiety 
scales than did normal students. 
Kumar et al conclude that though patients with sickle-cell disease 
who have had consistent family support and health care are not different 
from a matched peer group in adjustment, as judged by the tests given. 
However, patients showed a lower "self-concept", and thus might benefit 
from "guidance and especially reassurance to strengthen self-confidence" 
(M). 
b. Barrett et al, 1988 
Drue H. Barrett et al (6S) studied a group of 89 adult patients with 
sickle-cell disease being seen at a sickle-cell center at a hospital in 
Georgia. Barrett et al used the "Chronic Illness Problem Inventory" (CIPI) 
to assess psychosocial impairment in a range of areas, and also collected 
data on the number of acute emergency visits per month. 
Results of the "CIPI" showed that patients rated as most severe their 
problems with employment, followed by sleep, eating, and financial 
difficulties. In addition, patients reported difficulty in the areas of Body 
Deterioration, Activities of Daily Living, and Assertion. The lowest 
problem severity ratings were found in the scales of Physical Appearance, 
Cognition, and Marital Difficulty. Men scored higher than women on 17 
of the 18 scales, though not to a statistical significance of P < .05. 
Interestingly, there did not appear to be a correlation between scores on 
the "CIPI" and utilization of emergency services, years of sickle-cell 
disease, or age of the patients. 
65 
Kumar, p. 862 
Barrett, 1988 
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Barrett et al conclude that the studied population of patients with 
sickle-cell disease was having significant psychosocial distress, especially in 
the areas of employment, sleeping, eating, and finances, as well as in other 
areas. Although depression was not specifically measured, the authors 
speculate that their data may imply that "depression may be prevalent 
among this population” f66). They suggest that vocational rehabilitation 
and job training programs might benefit these patients. 
c. Leavell et al, 1983 
Sandra R. Leavell and Charles V. Ford (67) studied 16 adults with 
sickle-cell disease, including 8 men and 8 women, between the ages of 19 
and 53 (mean age 32), recruited in an unspecified fashion from two 
university hematology clinics in Nashville. The authors used a structured 
interview to assess mood, personality, education and background in the 
patients, and also employed the "State-Trait Anxiety Inventory" (STAI) and 
the "Schedule for Recent Events" (SRE). The "SRE" yields "Life Change 
Units" (LCU's) as a measure of recent life changes and stresses. The 
authors also attempted to contact the patients six months later to ascertain 
whether they had experienced symptoms of sickle-cell disease in the 
interim. 
66 
67 
Barrett, p.749 
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Results from the interviews and tests indicated that there was no 
consistent "specific characteristic personality or behavior problem 
associated with sickle-cell disease". However. 8 of the lb patients were 
diagnosed with a "psychiatric disorder", including among other diagnoses 
sociopathy, history of substance abuse with hallucinations, drug-seeking, 
and depression. In particular, "psychiatric impairment" was greater in men 
than in women. Medical complications experienced by patients before the 
study were also more severe with males than with females. In addition, 
those patients who had had high stress (increased LCU’s) in the previous 6 
months, and those with low social support, were more likely to report 
having experienced symptoms of painful crisis in the 6-month follow-up 
period I68). Finally, "State-Trait Anxiety Inventory" scores for the 16 
patients were not significantly different than those reported earlier for 
general medical patients (69). 
Leavell and Ford conclude that their data did not suggest a "specific 
characteristic personality or behavior problem associated with sickle-cell 
disease (such as manipulative, narcotic-seeking behavior), but rather a 
wide range of different types of personal adjustment to the disease" (70). 
Regarding the lower levels of both medical complications and psychiatric 
symptoms among women, the authors speculate that "women with sickle¬ 
cell disease who survive to adulthood are less disabled and therefore have 
a more 'normal' idjustment to life in spite of their disease" (71). Finally, 
they note that life stress, as well as lack of social supports, appears 
associated with increased symptoms of sickle-cell disease. 
See Leavell, 1983, p.28-29 
Leavell, p. 25-29 
Leavell, p.29 
Leavell, p. 29. 
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Note that the authors do not give figures on how many of their 
female patients had had children. One wonders what effect pregnancy, 
which in sickle-cell disease has a high rate of complications, might have 
had on the authors’ assessment that psychiatric morbidity was less in their 
female patients. 
d. Damlouji, 1982 
Namir F. Damlouji et al (72), compared 30 patients with sickle-cell 
disease with an age-, sex- and social-class-matched group of 30 patients 
with diabetes mellitus, all of them black, aged 15-56, from inner-city 
neighborhoods, recruited from patients seen at the Sickle-cell and Diabetes 
Clinics at The Johns Hopkins Hospital. The authors administered the 
"Social Functioning Schedule" (SFS) in a semi-structured interview, and the 
"General Health Questionnaire" (GHQ) to all patients in the study. In 
addition, the authors counted the number of medical complications noted 
in the charts of both groups of patients. 
Damlouji et al found that both sickle-cell disease and diabetes 
mellitus were associated with social disability and psychiatric morbidity. 
Overall, the patients with sickle-cell disease had more difficulties than the 
patients with diabetes mellitus in 4 of the 12 scales of the "Social 
Functioning Schedule" (employment, financial problems, child care, and 
spare-time activities). There were no significant differences noted between 
the scores of men and of women. Overall, in both groups of patients, the 
authors note that although social maladjustment (ie "SFS” scores) and 
emotional disturbance (ie. "GHQ" scores) correlated with one another. 
Damlouji, 1982 
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they did not directly correlate with the number of medical complications 
(77). Neither could age, marital status, nor educational level be shown to 
be associated with social maladjustment or emotional disturbance. 
Damlouji et al speculate that factors which might have contributed to 
the social disability and emotional disturbance tested in their patients with 
sickle-cell disease and diabetes mellitus might have included "chronicity of 
illness, lifelong and chronic dependence on the medical care system, and 
the fact that both sickle ceil anemia and diabetes are incurable". The 
authors suggest that the greater difficulties reported by patients with sickle¬ 
cell disease might have its basis in the fact that "the frequency and severity 
of painful crises are both unpredictable and out of the patients' control" in 
sickle-cell disease (74). 
They also conclude that social maladjustment and emotional 
disturbance may be independent of physical condition (as judged by 
number of complications). However, their argument on this point is 
weakened by their failure to define how they counted "medical 
complications". Did they, for example, count "functional asplenia" in the 
same way as they did "cerebrovascular accident"? No clue on this point is 
given in the article. 
Damlouji, 1982, p. 931 
Damlouji, p. 931 
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e. Bobo et al, 1989 
Loretta Bobo et al (7S) studied a group of 108 patients from the 
inner city of New Orleans, ages 15 and up, 48 of which had sickle-cell 
disease, and 60 of whom had asthma, as well as 50 of both groups’ 
unaffected siblings. Bobo’s group interviewed the patients by telephone, 
and employed selected scales from the Rand Health Insurance study to 
assess the patients’ attitudes about prior and current health, health outlook 
and worry/concern, resistance or susceptibility to illness, as well as 
rejection of the sick role and attitude about doctors. In analyzing the data 
collected, the authors looked both at each of these groups separately, and 
at the aggregate of patients with sickle-cell disease and with asthma (ie the 
"chronic disease group”). 
Bobo et al found that health perception scores were significantly 
lower for the chronic disease group than for their unaffected siblings on all 
scales. In addition, the patients with sickle-cell disease reported 
significantly poorer health than the asthma patients in half the scales, 
including "health outlook", "resistance/susceptibility", and "sickness 
orientation". Both the patients with sickle-cell disease and patients with 
asthma reported high ratings of their own attempts to "reject the sick role" 
(eg keep going, fight their disease), comparable with their siblings’ ratings. 
When asked to give their opinions of the medical care they received 
(in terms of access, continuity, financing, humaneness, quality of care and 
satisfaction), both chronic illness groups, as well as their healthy siblings, 
gave largely similar ratings overall. The only statistically significant 
differences among the groups were significantly lower ratings given by 
sickle cell patients in comparison to ratings by asthma patients in two of 
the scales: humaneness of care (59 vs 65) and satisfaction with care (58 
Bobo, et al, 1989 
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vs. 64). However, patients with sickle-cell disease did not report any more 
difficulty with access to health care, or with the costs of medical care, than 
did the patients with asthma or the group of health siblings. 
Bobo et al give several reasons why patients with sickle-cell disease 
might report lower levels of health perceptions and opinions of medical 
care in several scales. Given that patients did not report more difficulty 
with access to health care than the asthma patients or healthy siblings 
groups, Bobo et al speculate that 'These unfavorable ratings may have 
been influenced more by the chronic disease than the impact of services" 
(76). Thus, factors such as the recurring, unpredictable pain crises and 
early mortality of sickle-cell disease may have contributed to differences in 
the experiences of patients with sickle-cell disease and with asthma. 
However, the authors mention another factor possibly contributing to 
negative opinions of medical care in this case, namely, the recent 
discontinuation (for lack of funding) of a special clinic for patients with 
sickle-cell disease (77). Patients who had received comprehensive care at 
the clinic were suddenly forced to rely on the emergency department and 
outpatient clinics of the public hospital. Unfortunately, the study by Bobo 
et al. did not address specifically in interviews with patients what effect the 
discontinuation of the clinic had on their views of their own health and of 
the health care system (78). 
Bobo, p. 11 
Bobo, p. 12 
Bobo et al cite an article which is helpful in considering this question. Nicole 
Lurie and colleagues studied the effects on patients of termination from 
California’s Medi-Cal program for indigent adults. The same study instrument, 
from the Rand Corporation Insurance Study, was used by Lurie’s group, to 
demonstrate a fall in health perceptions after termination of Medi-Cal benefits. 
See Lurie, 1984 and Lurie, 1986 
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f. Vichinsky, 1982 
Elliot Vichinsky and colleagues have done particularly useful 
research into the psychology of the doctor-patient relationship in sickle-cell 
disease (7<>). In examining the conflicts surrounding the treatment of 
sickle-cell disease at their hospitals in Oakland and Berkeley, California, 
Vichinsky et al found that housestaff felt "marked anxiety surrounding the 
evaluation of pain" in patients with sickle-cell disease. Conversely, the 
authors found dissatisfaction among patients with the care they received 
during sickle-cell crisis. 
Reviewing the records of painful events requiring narcotic analgesia 
(a total of 1,295 painful events) in 152 patients in the previous year, the 
authors located the 31 patients of this group with the most crises and 
evaluated each one of them with a psychiatric examination. This 
preliminary data suggested that "depression, anxiety, and neuroses were 
frequently present in the chronically ill sickle cell disease patient" l80). 
Among other findings, psychiatric examination showed that "25 patients 
(80%) had clear-cut characterologic neuroses, including depression, 
hysteria, and hypochondriasis" (8I). 
In addition, Vichinsky et al studied the records of 101 patients 
receiving narcotic analgesics at their institutions (they do not clarify how 
this sample was chosen) in an effort to identify narcotic-related 
complications. The authors found that 6 patients had had "major motor 
seizures precipitated by large doses of demerol", 3 patients attempted 
suicide by drug ingestion (one died), 7 patients had "drug dependence", and 
79 
80 
81 
Vichinsky, et al, 1982 
Vichinsky, 1982, p.329-30 
Vichinsky, p.330, table 2 
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3 had "drug addiction” (82). No clarification is given about how these 
categories were defined in the chart review. 
Interestingly, of the 1295 painful events reviewed, all initially thought 
to be sickle-cell crisis, reviewed by Vichinsky et al, 31 episodes (ie 2%) 
were subsequently found to have had other causes. Of these, 6 proved to 
be cholecystitis, 5 to be metastatic pancreatic cancer (83), 4 to be deep 
vein thrombosis. 2 episodes proved to be due to acute narcotic withdrawal 
O. 
Vichinsky et al conclude that depression, anxiety, and neuroses are 
prevalent among patients with sickle-cell disease. After their initial review 
of the psychology of patients with sickle-cell disease in their institutions, 
the authors instituted a comprehensive program to coordinate pain 
management in sickle-cell patients. This program is discussed below under 
'Treatment of Sickle Cell Disease in the Emergency Department". 
- \ 
Vichinsky, p. 330, table 3 v 
It is not made clear in the article whether these 5 episodes of pain from 
metastatic pancreatic cancer were in the same patient 
84 Vichinsky, p. 330, table 4 
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3. Psychological issues: conclusions 
The six studies reviewed above are quite disparate in their 
approaches. Though five of the six studies employed at least one scalar (ie 
quantifiable) measure of personality, adjustment or psychological well¬ 
being, not one of these scales was employed in more than one study. In 
addition, patient samples and definitions of terms were different in 
different studies. Therefore, comparison of results among the six studies is 
difficult. 
Age appeared to have a strong effect on psychological morbidity in 
sickle-cell disease. Whereas Kumar’s sample of adolescents with sickle-cell 
disease was similar to a matched control group in terms of general 
adjustment and other measures, psychiatric morbidity in adult patients in 
other studies was prevalent. These adult patients reported difficulties with 
sleep, financial problems and body deterioration (Barrett), social disability 
and emotional disturbance (Damlouji), low health outlook, sickness 
orientation and dissatisfaction with medical care (Bobo). Patients in two 
studies reported that problems with employment were especially severe 
(Barrett and Damlouji). 
In two studies discussed above, sickle-cell patients were found to 
have greater psychological impairment than their peers with other chronic 
diseases, including diabetes mellitus (Damlouji) and asthma (Bobo). The 
authors cite a number of possible reasons for this marked psychological 
impairment in sickle-cell disease relative to other chronic diseases, 
including the early onset of illness in sickle-cell disease, the frequency and 
severity of painful crises, and the early mortality of sickle-cell patients. 
Perhaps most important, patients with sickle-cell disease have very little 
control over their illness, as painful crises thus far are both unpredictable 
and unpreventable. This is in contrast to diabetes mellitus, which can be 
largely controlled (at least in the short term) by insulin and diet, and to 
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asthma, in which bronchodilators and other therapies can markedly reduce 
morbidity. 
Two of the studies (Leavell and Vichinsky) employed structured 
interview and psychiatric exam to assess psychiatric health of sickle-cell 
patients. In Leavell’s study, 8 of 16 patients were found to have a 
psychiatric disorder, including sociopathy, history of substance abuse with 
hallucinations, drug-seeking and depression. In Vichinsky’s study, 25 of the 
31 patients with the most crises were found to have characterological 
neuroses, including depression, hysteria and hypochondriasis. Thus, though 
both Leavell and Vichinsky found psychiatric morbidity prevalent in their 
patients, neither found any specific type of psychiatric difficulty which was 
singular to patients with sickle-cell disease. 
In investigating the relationship between the patient with sickle-cell 
disease and his or her physician, one may ask whether or not the 
psychological stresses and impairment of sickle-cell disease predispose 
patients to dependence on pain medications. Unfortunately, the literature 
on the psychology of sickle-cell disease is not clear on this point. Though 
psychiatric morbidity appears common, it is so diverse in nature that no 
common thread leading to drug dependence can be identified. The topic 
of drug dependence and its prevalence among sickle-cell patients will be 
discussed further below. 
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D. Analgesics 
The literature on the treatment of sickie-cell pain is relatively broad, 
and considerable disagreement exists about the value and dangers of 
different classes of analgesics in treating the disease. Therefore, a brief 
overview of the literature on pain relief in sickle cell disease will be 
presented here, concentrating on the use of narcotic analgesics, especially 
in the Emergency Department setting. 
In dosing analgesics for patients with vaso-occlusive crisis, an 
understanding of the pharmacokinetics of various analgesics is pivotal. As 
Vichinsky points out, "duration of action of analgesia" refers to the period 
during which the patient experiences analgesia. This period is not 
necessarily the interval of adequate pain control l85). 
Peripherally acting oral analgesics have a role in mild or moderate 
pain of sickle-cell disease. For example, acetaminophen is a commonly 
used agent, especially in children l86). In addition, aspirin and other non¬ 
steroidal anti-inflammatory drugs may be used in children who are afebrile 
and without signs of infection, and may be especially helpful in bony pain 
(87). In one controlled study, the non-steroidal anti-intlammatorv agent 
diflunisal reduced pain towards the end of vaso-occlusive episodes, but not 
during the period of most intense pain at the beginning of the episode 
(**). 
See Vichinsky, 1982, p. 33 i 
Pearson. 1984 
Shapiro, 1989, p. 1034 
Perlin, et al. 1986 88 
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For more intense pain, however, more powerful, narcotic analgesics 
are often necessary, starting with oral agents. On the weaker end of the 
spectrum of narcotic analgesics is oral codeine, which is often prescribed 
with a peripherally acting analgesic (89). Codeine would most commonly 
be prescribed for outpatient management of moderate pain f90). 
Stronger opioids which can be given orally include hydromorphone, 
oxycodone, methadone, and immediate and sustained-release morphine. 
These oral medications may be used even for the management of severe 
vaso-occlusive crises (91), with an analgesic effect comparable to that of 
parenteral medications. Use of oral narcotics has been described in the 
Emergency Department, but admission may still be necessary for proper 
adjustment of dosage of monitoring of the patient (92). Nausea and 
vomiting may limit the usefulness of the oral narcotic agents. In addition, 
poor absorption of morphine may limit its use as an oral agent. 
If admission and treatment with parenteral medication is necessary in 
vaso-occlusive crisis, morphine is considered an especially good choice 
(93). However, if untoward effects such as pruritus, nausea and vomiting 
occur and are persistent, another agent such as hydromorphone may be 
chosen. 
Though meperidine is often prescribed for management of severe 
vaso-occlusive crisis, a number of dangers are associated with its use in 
Shapiro, 1989, p. 1034 
Pearson, 1984, and Vichinsky, 1982 
Friedman EW, 1986 
Friedman EW, 1986 and Shapiro, 1989 
Vichinsky, 1982, p. 331 (table 5) and Shapiro, 1989, p. 1035 93 
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patients with sickle-cell disease (94). Meperidine has a long-acting 
metabolite (normeperidine) which has only slight analgesic activity, and 
has been associated with excitation of the central nervous system, 
dysphoria, and seizures (95). Excretion of normeperidine into urine is 
decreased when urine is alkaline, which could lead to accumulation of this 
metabolite in the renal tubular acidosis of sickle cell disease (%). In 
addition, in one study meperidine levels in patients with sickle-cell disease 
were lower than those in control patients, though both groups had received 
the same amount intramuscularly (97). Thus, meperidine, at least when 
given by the intramuscular route, may be less effective in relieving pain in 
sickle cell patients than in other patients. 
For patients in vaso-occlusive crisis who need parenteral analgesia, 
Vichinsky recommends a fixed dosing interval for morphine of 2.5 hours 
(at .15 mg/kg), to provide a constant level of analgesia. After the first 48 
hours, the dose can usually be tapered. Once the dose of parenteral 
morphine has been lowered to half the initial dose, Vichinsky recommends 
switching to an equianalgesic dose of oral narcotics given every 4 hours 
(*). 
Cole and colleagues report on the use of continuous intravenous 
narcotic infusions for the treatment of painful crisis in children ("). They 
studied a total of 98 painful crises in 38 patients. Of the 98 episodes of 
painful crisis, 76 were treated with continuous infusion of opioids 
Shapiro, 1989, p. 1035 
Tang, 1980 
Szeto, 1977, and Shapiro, 1989 
Abbuhi, 1986 
Vichinsky, 1982, p. 331 
Cole, 1986 99 
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(morphine or meperidine) given on a standard protocol, and 22 were 
treated with intermittent intravenous bolus injections of meperidine. The 
authors found that patients given continuous infusions required more 
narcotic to control their pain and had more side effects than those treated 
with bolus injections alone (,0°). 
Side effects of continuous intravenous narcotic infusions reported by 
the authors included nausea and vomiting, lethargy, and abdominal 
distention, as well as a significant incidence of chest syndrome, and severe 
respiratory distress in three patients. They note that "narcotic withdrawal 
or addiction was not observed" (101). Despite the many ill effects seen 
with continuous opioid infusion, the authors conclude that this modality is 
safe and provides adequate pain relief during vaso-occlusive crisis. 
Patient-Controlled Analgesia (PCA) has been tried on a very limited 
basis for patients with sickle-cell disease. For example, Schechter et al 
have reported on a preliminary trial of PCA with adolescent patients, in 
preparation for a randomized controlled clinical trial. (102). Their sample 
consisted of only 3 patients, aged 12, 11, and 17 years old. The authors 
found that doses of morphine required for pain control were higher than 
expected. However, morphine requirements decreased on successive days 
as the pain crisis resolved, which was taken by the authors to imply that 
the drug was not being abused (103). 
The authors argued that use of PCA broke the cycle of 
undermedication of sickle-cell pain, in which continued pain leads to a 
100 Cole, 1986, p. 1255 
101 Cole, 1986, p. 1255 
Schechter et al, 1988 
Schechter et al, 1988, p. 109 103 
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"seemingly undue interest in medication" by the patient, leading to 
suspicion of drug-seeking by the physician and continued undermedication. 
Interestingly, the authors believe that "deeply entrenched attitudes" in the 
medical profession toward patients with sickle-cell disease led to the 
refusal of one hospital to participate in a clinical trial of PCA for patients 
with sickle-cell disease (l04) 
It is important to note that even if Patient-Controlled Analgesia is 
not available, many of the same advantages can be gained with a flexible 
dosing schedule (105). 
Because there are no prospective, controlled studies comparing 
opioids and routes and schedules of administration in sickle-cell disease 
(106), it is difficult to make a definitive judgement on the efficacy of one 
versus the other. The reader is referred to the literature cited above for 
more detail on this subject. 
Schechter et al, 1988, p. 112. It might be noted that at the particular hospital 
cited by Schechter et al, PCA was already an established modality for treatment 
of post-operative pain. 
105 
106 
See Angell, 1982, p.98-99 and Shapiro, 1982, p.1036 
Shapiro. 1989, p. 1036 
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E. Narcotics addiction in patients with sickle-cell disease 
Because "addiction" to narcotics is defined in so many ways, it is very 
difficult to compare figures on addiction among different authorities in the 
literature. However, because this issue is so important to the study at 
hand, an attempt will be made here to survey the literature on this subject. 
Generally, authors range from those offering personal impressions of the 
frequency of addiction to those who give statistics, but none has clearly 
defined the criteria for classification of a patient as "addicted". Thus, it 
could be argued that assessments of the addictive potential of opioids cited 
here reflect primarily the range of physicians’ attitudes on the subject, 
rather than "hard data". 
There is a wide spectrum of opinion on the addictive potential of 
opioids. At one end of the spectrum are those who feel that addiction in 
patients with sickle-cell disease is rare indeed. One writer from Great 
Britain, for example, Brozovic (1986), maintained that "not one of the 610 
Brent, Camberwell, Haringey, and City and Hackney patients with sickle 
cell disease is known to be a drug addict" (,07). In fact, this author felt 
that 
"to suggest that the pain of trunk crisis can be alleviated by 
reassurance and paracetamol and that administration of opioid 
analgesia leads to drug addiction and dependence pushes us 
back to where we were ten years ago when every patient with 
sickle cell disease was regarded as either a malingerer or a drug 
addict." 
107 
108 
Brozovic, 1986, p. 624 
Brozovic, 1986, p. 624 

Literature Review Page 47 
Cole et al (1986) suggest that the withholding of analgesics may 
actually encourage addictive behaviors in children: 
"Inadequate pain management may ultimately lead the patient 
to seek pain relief by other than accepted means, a practice that 
could ultimately lead to addiction. Morphine or meperidine 
given in the hospital for a period of several days should not - 
and in our experience does not - result in drug dependence." 
O 
Cole et al note that no "addictive behaviors" were observed in any of their 
patients, nor w'ere symptoms of withdrawal. 
Other writers express similar views, but with less conviction, as in this 
quote from Heller (1988): 
"We are reasonably sure that these patients take the [narcotic] 
drug only for this purpose [of pain control] and are not 
addicted, and we are confident that the drug does not end up 
on the street market." 
O 
This author describes a group of frequent users of the Emergency 
Department, around whom the question of addiction appears to arise: 
"There are a few patients with such severe pain that they 
require Demerol compound, Dilaudid tablets, or other narcotic 
drugs. They are known to medical staff, come to the 
emergency department at frequent intervals, and are often 
109 
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Cole, 1986, p. 1258 
Heller, 1988, p. 703 
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hospitalized, and the risk of addiction can be disregarded in 
relationship to the obviously excruciating pain and severity of 
their disease". 
(m) 
The author concludes that "the need for pain relief is stronger than our 
fear of addiction." 
Other writers express considerably more concern about the addictive 
potential of narcotics. For example, Charache (1981) evinces a high 
degree of suspicion about drug-seeking behavior: 
"Since drug-seeking is learned behavior, the physician must 
control the dose and time of administration of narcotics rather 
than give the patient the opportunity to seek the drug and have 
that behavior rewarded. There are some addicted sicklers; in 
my experience they all became addicted outside the hospital, 
and most admit they are addicted." 
(m) 
Charache does not make clear his criteria for addiction, nor does he clarify 
the meaning of his remark that patients become addicted "outside the 
hospital". 
Vichinsky et al are singular in quantitating the risk of opioid 
addiction in their patients. In reviewing the records of 101 patients, 
apparently both adults and adolescents, for major and minor complications 
of narcotic use in sickle-cell disease, the authors uncovered 6 patients who 
had seizures from large-dose demerol, 3 suicide attempts (by overdose with 
in 
112 
Heller, 1988, p. 703 
Charache, 1981, p. 196 
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narcotics), 7 cases of "drug dependence" and 3 cases of "drug addiction" 
(n3). Of those classified as "drug dependent", none experienced 
withdrawal symptoms after counseling and elimination of narcotics. It is 
less clear how "drug addiction" was defined (1U). For this reason, it is 
uncertain how the authors’ estimate of the prevalence of "drug addiction" 
(3%) is to be compared with other studies. 
Thus it appears that there is little data on the prevalence of addiction 
among patients with sickle-cell disease treated with narcotic analgesics. 
More information is available on the issue of addiction in patients with 
other illness characterized by pain, for example, chronic pain syndrome, or 
systemic illness such as malignancy. As this very broad field, the reader is 
referred to other articles on these topics (1,s). 
F. Treatment of sickle-cell disease in the Emergency Department 
Treatment of sickle-cell disease in the Emergency Department 
presents many challenges. These challenges have been discussed in a 
number of articles, three of which will be reviewed in some detail here. In 
one article, the type of pain relief given to children and to adults with 
sickle-cell disease visiting Emergency Departments is compared. In 
addition, two articles describe the authors' experience with the use of 
management protocols for treatment of sickle-cell disease in the 
Emergency Department. 
Vichinsky, 1982, p. 330, table 3 
Vichinsky, 1982. p. 330, p.330 
See for example Bonica, 1990, p. 598, Brodner, 1978, Ready, 1982, and Portenoy, 
1986 
115 
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1. Selbst and Clark, 1990 
Selbst and Clark sought to determine whether children with acute, 
painful conditions were treated in a similar fashion as adults with similar 
conditions. To this end, they examined the treatment of pain in sickle-cell 
crisis, lower-extremity fractures, and second- or third-degree burns, in 119 
children treated at Children's Hospital of Philadelphia ED, as well as in 
162 adults treated for the same conditions at the Medical College of 
Pennsylvania ED, over a seven-month period. Charts from these 
institutions were assessed retrospectively for patient diagnosis, disposition, 
and use of narcotic and nonnarcotic analgesics while in the ED as well as 
after discharge from the ED. 
Fifty-three of the patients whose charts were reviewed by the authors 
had sickle-cell disease, including 27 children (defined as patients under 19) 
and 26 adults (defined as patients from 19-65). No patient over 65 years 
old had been treated for sickle-cell crisis. Patients with sickle-cell crises 
complicated by fever, stroke or other problems were excluded from the 
analysis. Analgesics prescribed were almost exclusively narcotic. 
Selbst and Clark found that whereas all of the adults with sickle-cell 
crisis (26/26) had received pain medications in the ED, only 74% of the 
children with sickle-cell crisis (20/27) had received medication for pain, 
leaving 7 children who had received no pain medication at all. This 
difference in prescription of pain medication in the ED to children and to 
adults was significant to P < .05. However, differences in the prescription 
of analgesics on discharge from the ED to children was not significantly 
different from that to adults. Overall, for all three acute painful 
conditions examined by the authors, children received analgesics 
significantly less frequently than adults did. 
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The authors speculate that reasons for the less frequent prescription 
of analgesics to children are varied, and include fear of drug addiction, 
concern about respiratory depression, misconceptions about analgesia 
needed by children, and the more specific and vehement requests for pain 
medication by adults. The authors note that the prevalence of addiction 
among their adult patients is unknown, and that physicians’ suspicions 
about addiction may have influenced the amount of narcotics they 
prescribed (116). 
While useful, Selbst and Clark’s study is somewhat limited by its 
retrospective nature, and its failure to analyze differences in prescription 
patterns between the two institutions, one of which (CHOP) serves 
primarily children. 
2. Powers, 1986 
Robert Powers has reported on a study of the use of individualized 
management protocols for treatment of sickle-cell pain, [n the study, 
conducted in the Emergency Department of the University of Virginia 
Medical, 5 black men between the ages of 25 and 33 years were identified 
as "chronic ED users". These patients were advised that standard ED 
management of pain would consist of oral hydration, oxygen, and oral 
meperidine or methadone. Parenteral narcotics were given only at the 
request of the primary physician, or if the patient required admission for 
pain control (l17). 
Individualized treatment protocols, developed in concert by a primary 
physician and a hematologist responsible for the patient, were kept on 
hand in the Emergency Department, along with logs of ED visits. It is 
116 
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Selbst, 1990, p. 1012 
Powers, 1986, p. 267 
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important to note that the "protocol for pain was begun only after history, 
physical examination, and appropriate laboratory testing excluded true 
sickle cell crisis, infection, or serious co-existent illness" ("8) 
In the year following institution of the program for the five patients, 
Powers documented a decrease in the number of ED visits (from 163 to 
56), as well as mean length of stay in the ED, percentage of visits given 
IM meperidine, and mean dose of IM meperidine. After informal surveys 
both of staff and of patients. Powers concluded that the program had been 
a success in reducing ED usage, in improving care, and in minimizing 
"confrontations between sickle-cell disease patients and professional staff". 
The usefulness of Power’s article is somewhat limited by the small 
size of his sample (5 patients). In addition, it should be pointed out that 
misgivings must arise from Power’s apparent belief that "true sickle cell 
crisis" could be excluded by "appropriate laboratory testing" (n9). In fact, 
as noted above, exclusion of "true sickle cell crisis" was a precondition for 
initiation of the treatment protocol. The implication seems to be that the 
protocol was used only on patients with proven drug addiction or drug¬ 
seeking behavior. Thus it appears that a fundamental misunderstanding of 
the limitations of diagnostic testing in sickle cell disease was at the heart of 
Power's study. 
118 
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3. Vichinsky, 1982 
Another study which examined the effects of a management protocol 
for sickle cell disease on utilization of Emergency Department services was 
conducted by Vichinsky et al. After doing a survey (described above) of 
the prevalence of depression and other psychiatric complaints in sickle-cell 
patients, the authors instituted an intensive multidisciplinary treatment 
program for patients with sickle-cell disease. The program included 
counselling and group therapy, vocational rehabilitation and school tutorial 
programs, and a standard protocol for medicating patients in both the 
inpatient and outpatient settings. 
| 
Vichinsky et al identified 10 patients (age range 19 to 41) who "fit 
into the chronic pain syndrome category", and examined their utilization of 
the Emergency Services and hospitalizations in the 6 months before and in 
the 6 months after institution of the program. The authors found a 58% 
decrease in Emergency Department visits and a 44% decrease in pain- 
related hospitalizations. They conclude that their multidisciplinary 
approach can "significantly reduce morbidity in sickle cell disease" (12°). 
The chief limitation of Vichinsky's data on ED visits is his vague 
description of the inclusion criteria for patients. It is unclear how the 
"chronic pain syndrome category" is defined. Thus, it is difficult to judge 
how such a program would affect ED use by sickle-cell patients in general. 
In addition, it is unclear whether the decrease in utilization of emergency 
services reflects a decrease in morbidity from the standpoint of the patient. 
Nor is it clear whether patients are seeking their care at another 
Emergency Department. 
120 Vichinsky, 1982, p.332 
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4. Emergency Department Treatment — an overview 
Clearly, research into the treatment of sickle-cell crisis in the 
Emergency Department has been relatively sparse. What emerges most 
clearly from a number of articles on the subject is a sense of anger and 
helplessness, as in this quote from Power’s article: 
"Frustration and anger often develop in ED staff as they are 
repeatedly confronted with patients demanding narcotics for 
relief of pain, which may be unaccompanied by objective signs 
of illness." 
(m) 
The patient with sickle-cell disease who has frequent painful crises 
may be considered together with other frequent users of Emergency 
Department. These patients, labelled "frequent flyers" in one article 
(122), are a source of special frustration for Emergency Department staff. 
However, little is known about this small but costly group of patients. 
Several studies have shown that frequent visitors to the Emergency 
Department tend to have a high incidence of chronic psychiatric 
conditions, alcoholism, and recurrent medical problems (123). 
Pierce (1990), in a retrospective study of patients in Memphis who 
returned to the ED within two days of initial registration, found that 
patient-related factors (that is, in which the reason for return was 
"primarily the fault of the patient") accounted for 53% of return visits. 
Note that in Pierce's study, repeat visits by patients with sickle-cell disease 
lz1 Powers, 1986, p. 267 
'22 Schuckman, 1989 
123 Pierce, 1990, and Purdie, 1981 
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were lumped under "illness-related return visits", as an example, like 
asthma, of a "recurrence of a chronic disease process" (124), rather than 
under "patient-related visits", as drug-seeking and narcotics addiction might 
have been. 
124 Pierce, 1990, p. 755 
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G. Comments on the literature review and its value for the present 
study 
The literature review above has touched on a number of aspects of 
sickle-cell disease which present unique problems for the physician patient 
relationship. Not only can painful crisis not be diagnosed on any objective 
basis, presently available treatments are merely symptomatic. In fact, 
physicians may feel that treatment of sickle-cell disease with narcotic 
analgesics may have problematic value at best. To these difficulties on the 
side of the physician can be added the painful, disabling and unpredictable 
nature of the disease for the patient, which may lead to a variety of 
psychosocial difficulties. The interaction between these two groups of 
frustrated people - physicians and patients - in the hectic environment of 
the Emergency Department has the potential for considerable conflict. 
It is against this backdrop that the present study of the physician- 
patient relationship at Yale-New Haven Hospital takes place. In 
formulating questions to answer in the present study, the literature review 
will be an important quide. Among others, questions suggested by the 
literature review include the following: 
1) In light of the effects which age and sex appear to have on 
psychosocial adjustment in sickle-cell patients, how does 
hospital use at Yale-New Haven Hospital differ among sickle¬ 
cell patients of various ages, and between males and females? 
2) In light of research showing positive effects of strategies such as 
management protocols on the care received by very frequent 
ED visitors, how many sickle-cell patients visit the YNHH 
Emergency Department with high frequency? How do their 
illness and their patterns of hospital use differ from those of 
less frequent ED visitors? 
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3) In light of research showing varying degrees of tension 
surrounding the issues of narcotic dependence and drug-seeking 
among patients with sickle-cell disease, how do issues of drug¬ 
seeking and drug abuse affect the care which patients receive at 
Yale-New Haven Hospital? 
These questions have formed the basis of the design of the present 
study, and will be important in evaluating its results. 
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III. Methods 
A. Methods -- General Introduction 
The present study was conducted in three phases. In the first phase 
("phase 1"), the goal was to characterize in general utilization of hospital 
services at Yale-New Haven Hospital by patients with sickle-cell disease. 
To this end, computer records of patient visits to YNHH and the YNHH 
ED over the period of one year (October 1, 1989 to October 1, 1990) were 
combed for visits by patients with sickle-cell disease, by reference to ICD-9 
i codes and complaint descriptions recorded for each visit. The frequency 
of ED visits and admissions could then be examined for various groups of 
patients, and breakdowns made by gender, age and frequency of ED visits. 
A particular goal of this process was to identify, if possible, a group of 
patients with sickle-cell disease with especially high utilization of ED 
services. 
In the second phase of the study ("phase 2"), telephone interview was 
used to gain an understanding of the medical-care experiences of the group 
of high-frequency ED users. The interview in each case followed a 
standard format, and included both multiple-choice questions and open 
questions. Of the 12 patients with sickle-cell disease w7ho used the ED 
with the greatest frequency during the study period, 4 could not be reached 
for various reasons. The full interview was done with 8 patients, including 
the top 6 ED users 19 years and older. 
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B. Phase 1 
1. Phase 1 Data Collection 
The methods of the first phase of the present study will he described 
first. A computer program was written to examine the hilling records of 
YNHH over a one-year period (October 1, 1989 to October 1, 1990), in 
order to develope a general picture of the utilization of medical services 
by patients with sickle-cell disease. 
The data examined in this phase of the study was originally contained 
in the general billing data of YNHH. The computer program designed to 
study this very large data base examined every "record" of the data base 
individually. Therefore, the first task will be to describe how a typical 
"record" is added to the data base, and what information it contains. 
Each "record" of the data base represents data about an entire visit 
which is billable by YNHH (not only those bills which were actually 
collected). All the information about a single visit is kept under the same 
record. For example, every time a patient visits the YNHH ED, a record 
of the visit is generated, which includes basic demographic information 
(age, gender, address and phone number etc.), as well as some information 
about the visit itself (a short description of the complaint or diagnosis, 
eventual disposition, as well as the expenses incurred). After being seen in 
the ED, the patient might be discharged from the ED, and the record 
would then be closed. If, on the other hand, the patient goes on to be 
admitted, information on the admission (including discharge diagnoses, 
disposition, and, of course, expenses) is included under the same record. 
Thus, for a patient admitted to the hospital from the ED, registration 
information about the original ED visit is contained in the same record as 
information on the further admission to the hospital. 
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Patients who had incurred a hospital bill from any service of the 
hospital were identified and included in the patient sample. Expenses 
incurred by patients were classified by "source", that is, by the party that 
referred the patient for some test, treatment, or admission. The source 
might by the Emergency Department, a patient’s private physician, the 
Yale Hematology Clinic (which functions as a quasi-independent practice 
group of Yale Faculty), or any of a number of institutions, such as nursing 
homes or Health Maintenance Organizations. For the purposes of the 
present study, the "source" of a given patient visit was classified to be 
either "Emergency Department" or "non-Emergency Department". 
a. Operation of the Search Program: First Run 
The computer program examined every visit record by all YNHH 
patients between October 1st, 1989 and October 1st, 1990. For each 
record encountered by the program, two fields of data were examined for 
clues that the visit was by a patient with sickle-cell disease, namely, the 
"complaint description" and the ICD-9 diagnosis codes. An indication of 
sickle-cell disease in either field led the program to copy the record to a 
data file. The search criteria for these two fields detail will now be 
described in greater detail. 
The description of the patient’s complaint, recorded at the patient’s 
registration, was searched for an appearance of the words "sickle-cell 
crisis", "sickle crisis", "SSD crisis", or any of a number of combinations of 
such key words (see appendix for the actual search criteria). It should be 
noted that for a number of visits no complaint description was recorded. 
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The program also searched the ICD-9 codes recorded for each visit 
for the code "282.6" (IJ>), indicating either sickle-cel! disease or Sickle-C 
disease (ie double heterozygosity for hemoglobin S and hemoglobin C). 
Up to nine ICD-9 codes are assigned to each visit by specially trained 
coders in the Office of Professional services of YNHH. It should be noted 
that the ICD-9 diagnosis numbers were not infrequently inaccurate, as 
seen, for example, in the coding of 282.5, meaning "sickle-cell trait", as a 
l 
diagnosis for patients with known homozygous sickle-disease. Such records 
with miscoded ICD-9 diagnoses would typically be picked up in spite of the 
miscoding by their complaint descriptions. 
| 
The program thus picked up all visits with a complaint description 
containing the key words "sickle cell" (etc.) OR with an ICD-9 code 
indicating sickle-cell disease. Though this process picked up patients with 
sickle-cell disease with what we felt was maximum sensitivity, it also 
picked up a number of spurious entries, usually identified by the complaint 
description. For example, the complaint description for one visit might be 
recorded as "SS pain crisis”, which proved on inquiry to have referred to 
"substernal" pain crisis, or myocardial infarction. These spurious entries 
were usually obvious on manual inspection, and were removed. 
Undoubtedly, other spurious entries remained undetected in the data 
file. One example of a spurious entry which might remain in the data file 
would be a visit with no recorded complaint description, and an ICD-9 
code mistakenly recorded as indicating sickle-cell disease. In particular. 
N e that the ICD-9 code "282.6" excludes sickle-cell thalasemia and sickle-cell 
trait. 282.6 does include the subcodes 
282.60 ("sickle-cell anemia, uspecified"), 
282.61 ("Hb-S disease without mention of crisis"), 
282.62 ("Hb-S disease with mention of crisis"), and 
282.63 ("Sickle-cell/Hb-C disease"). 
However, these subcategories were not completely reliably coded by the Office 
of Professional Services, so no further use was made of them. 
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patients with sickle-cell trait might conceivably be expecially likely to 
i 
mistakenly receive an ICD-d code for sickle-cell disease. The number of 
spurious entries is difficult to estimate, but it appears to be very small, 
judging from comparisons of the data file with a chart review of a limited 
i number of patients (ie those chosen later for interview). However, time 
did not permit confirmation of the validity of the 1033 records by chart 
review. 
b. Operation of the search program: second run 
There remained an additional source of possible error in the data, 
namely, the fact that visits lacking a complaint description (or having, for 
example, a misspelling in a key word, such as "sikcle cell disease"), and 
also lacking a proper ICD-9 coding for sickle-cell disease, would escape 
detection. We could overcome this problem at least for patients who had 
been picked up on some other visit, by doing a second run through the 
data files. 
In this second run, a second computer program (a modification of the 
first) searched through all records for the study period. This time, 
however, the program searched for all the patients (by unit number) who 
had been identified on the first run. This second run ensured that if a 
patient had been identified even once throughout the study period, all of 
his or her visits to YNHH in that period would be included in the final 
data file. Thus, the only visits that escaped detection were by patients who 
had been not been identified during any visit during the entire study- 
period. 
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It is important to remember that this process of data collection aims 
to identify ED visits and hospital admissions by all patients with sickle-cell 
disease in the study period, not just incidents of sickle-cell crisis. Although 
a large proportion of the visits are likely to be for treatment of sickle-cell 
crisis pain, other visits may be for treatment of any number of other 
illness, which may or may not be related to sickle-cell disease. 
Unfortunately, neither the complaint descriptions for ED visits nor ICD-9 
diagnosis codes were recorded accurately enough in hospital billing records 
for them to be useful to us in distinguishing crisis pain from other reasons 
to seek medical attention. 
Another limitation to the process of data collection used here is an 
unavoidable selection bias towards patients who seek medical attention for 
their disease at YNHH. The data does not include patients in the 
community with mild disease, who passed the study year without seeking a 
doctor. Other patients may have seen a private physician during the year, 
but may not have been hospitalized at or been billed for services at 
YNHH. Still other patients may have preferred to travel to other hospitals 
to be treated for crisis pain. Because such patients are not included in the 
data, the data does not represent a sample of all the patients in the 
community with sickle-cell disease. 
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2. "Directly Counted" Variables 
The original data file generated as described above contained 1033 
records, each one corresponding to a visit to YNHH by a patient with 
sickle-cell disease between Oct. 1, 1080 and Oct. 1, 1000. We then counted 
the visits made by each patient, using a computer program specially written 
in dBase IV programming language. For each patient, the program 
counted 
1) total visits 
2) visits to the Emergency Department 
3) total admissions 
4) admissions via the Emergency Department 
5) days spent in the hospital during admissions 
In addition, a separate program counted Emergency Department visits and 
admissions for each month of the study period. 
The data files generated by these counting programs - now with each 
record corresponding to a single patient - were then imported into 
EXCELL spread sheet format for analysis. 
3. Patient ages 
Age was calculated for each patient by subtracting the patient's birth 
year from 19%. which was the year into which most of the study period 
fell (Oct. 1, 089 to Oct. 1, 1990). 
For the purposes of the analysis, a "younger patient" was defined to 
be 18 years old of age or younger (ie born in 1972 or later), and an "adult" 
was defined to be 19 years of age or older (ie born 1971 or earlier). This 
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division of patients into "younger" and "older" patients does not necessarily 
reflect whether a patient was treated as a child or as an adult (ie in the 
pediatric vs. adult side of the ED, clinics, or inpatient units). 
Three children with sickle hemoglobin were born during the study 
period, and stayed overnight, thereby accounting for three admissions. 
Sickle-cell disease was an incidental finding in these cases (found on 
routine screening), and not the reason for admission. These three children 
were removed from the data set. 
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C. Phase 2 Methods (interviews with patients) 
1. The patient sample 
Interviews with patients were at the heart of the present study. The 
group of patients targetted for interview were those sickle-cell patients 19 
years and older with the highest utilization of emergency services at Yale- 
New Haven hospital as identified by the computer survey of hospital visits 
by sickle-cell patients in the year-long period between 1 Oct. 1989 and 1 
Oct. 1990 (phase 1). Approval by Human Investigations Committee was 
obtained before research commenced. 
Originally, the 12 patients with the highest number of ED visits in the 
study period were chosen to be interviewed. All of them were sent a 
letter describing the study, and requesting their participation. Of the 12 
patients, 4 could not be contacted: 1 Patient had an unlisted phone 
number, and did not visit Hematology Clinic or respond to letters. 
Another patient was found to have expired by gunshot in late 1990. 
Another patient was dropped from the list when letters to his address were 
returned, and no telephone number for the patient could be found. Still 
another patient agreed happily to be interviewed, but in spite of many 
intervie appointments and phone calls was never at home with enough 
time to be interviewed. 
The remaining 8 patients were interviewed in the time period from 
January 30, 1991 to March 7, 1991. Of these 8 patients, 2 patients had no 
telephone, but were able to be contacted when they visited Hematology 
Clinic. Interviews were then arranged with these 2 patients in person. 
The other (3 interviews were done by telephone. 
The 8 patients interviewed included the 6 most frequent adult visitors 
to the ED with sickle-cell disease during the study year. The other 2 
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patients were ranked number 10 and number 12 in number of ED visits, 
respectively. The 8 patients together accounted for 170 Emergency 
Department visits during the study period, or 60% of all ED visits by 
adults (age > = 10) during the study period; numbers of ED visits among 
them ranged from 6 to 50. Three patients were male, and five were 
female. 
The average age of the sample was 31.0 years, with ages ranging 
from 23 to 41. Two 23-year-old female patients, though in an age group 
normally seen by the adult medical service, continued to be seen by the 
pediatric service. Because the organization of services to these two 
patients was different than it was for patients seen on the adult side of the 
ED. they will be considered separately. 
2. The interview format 
Patients w’ere interviewed by phone (or if necessary, in person), using 
a standard interview format. The format was based originally on the 
questions asked in the 1986 National Survey of Access to Health ( ). 
Considerable changes were made in the original questions as they were 
adapted for use with sickle-cell disease patients. The survey questions are 
included in the appendix. The average interview duration for the 8 
interviews was 57 minutes, with a range of 45 to 70 minutes. 
Briefly, the survey asked questions in the following areas. 
1) Where does the patient receive his or her care? 
2) Experiences with Hematology Clinic 
I 126 Freeman 1986 Note that no attempt was made to compare the answers to 
questions in the present study to corresponding answers to the 1986 survey 
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3) Experiences with the Emergency Department 
4) Experiences as an inpatient 
5) Compliance with doctor's orders 
6) Disability 
7) Pain medication 
8) Access to medical care 
9) General Background, education, marital status 
Many of the questions were multiple choice, to allow comparison of 
responses by different patients. However, for most of the the sections 
there was an open question to record each patient's responses in his or her 
own words. 
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S V. Results 
A. Phase 1 Results 
1. Introduction to phase 1 results 
In this section, results of the computer survey of visits of patients with 
Sickle-cell disease to Yale-New Haven from Oct. 1,1989 to Oct. 1,1990 will be 
presented. The results will be organized to answer the following questions: 
1) Who were the the patients with sickle-cell disease seen at Yale- 
New Haven Hospital? What what was their overall distribution 
in terms of age and gender? 
2) How much did sickle-cell patients use hospital services in toto? 
3) How did hospital use differ for patients of different age groups 
and between males and females? 
4) How did hospital use differ for patients with various levels of 
utilization of ED services? In particular, what patterns of hospital 
use can be found among patients with sickle-cell disease who 
frequently visit the Emergency Department? 
5) Do visits to the Emergency Department follow cyclical patterns 
over time? Especially, does the frequency of visits vary with 
temperature or season? If so, are these patterns different for 
young patients than for older patients? 
These questions will be answered by reference to 10 charts, which will 
be provided in the succeeding pages. For more exact numbers, the reader 
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may turn to the 7 tables of the results, placed next to the corresponding 
charts. 
An overview of the sample of patients with sickle-cell 
disease 
See tables 1 and 2, and charts 1 and 2 
A total of 132 patients with sickle-cell disease were identified. They 
had a mean age of 21 years. 48 were male, and 84 were female. 
Patients visited the Emergency Department a total of 422 times during 
the study year. This represented an average of 3.2 visits per patient per year. 
Patients in the sample were admitted a total of 164 times, and they spent a 
total of 969 days admitted in the hospital. Admissions lasted a mean average 
of 5.9 days long. 
Of the 422 visits to the Emergency Department. 131 (31.0%) resulted 
in admission. Of the 164 admissions, 131 (79.9%) were via the Emergency 
Department. 

Results Section Page 71 
3. Analysis of results by gender and age 
See tables 1 through 4, and charts 1 through 4 
Chart number 1 shows a breakdown of hospital use by age groups. As 
these data demonstrate, sickle-cell patients seen at Yale are predominantly 
young. Of the 132 patients, 33 (25%) were 10 years or younger, and 33 
(25%) were between 11 and 20. Thus, of all the patients seen. 50% were in 
the first two decades of life. 
The 21-to-30 age group was the largest, with 35 patients (27% of the 
total number). But in age groups older than this, numbers fell off sharply. 
Only 21 patients (15% of the total number) were in the 31-to-40 year group, 
and 6 patients (5% of total) were in the 41-50 age group. Only 4 patients in 
the sample were older than 51 years. 
Visits to the Emergency Department varied widely among different age 
groups. By far the greatest proportion of ED visits was accounted for by 
members of the 21-30 year age group. Patients between 21 and 30 years 
accounted for 37.9%) of all ED visits, out of proportion to their numbers 
(26.5% of total) (127). As graph 1 shows, patients in successive age groups 
to "either side" of the 21-30 year age group visited the ED proportionately 
less and less. 
Chart 1 demonstrates a similar peak in the numbers of admissions and 
hospital days for various age groups; this time, however, the peak lies in the 
11-20-year age group. Patients in this group were admitted 47 times (32% of 
127 It is of note that the 3 patients who visited the ER with the greatest frequency 
were all over 30 years old. Thus, the peak of ER visits in this age group is not 
simply due to skewing by the 3 top ER visitors. 
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total) and spent 312 days in the hospital (32% of total), somewhat out of 
proportion to their numbers (25% of total). 
There was a striking predominance of females in the sample (See charts 
2,3 and 4). Of 132 patients in the total sample, 84 (64%) were female, and 
48 (36%) were male. These gender proportions were similar both for patients 
18 years and younger and for patients 19 years and older. 
Use of emergency services by patients with sickle-cell disease at Yale- 
New Haven Hospital differed somewhat by gender. As chart 2 shows, female 
patients, partly reflecting their greater numbers in the sample, predominated 
overall in total visits to the ED, with 56% of ED visits by females, and 43.1% 
by men. However, actual "per patient" visits to the ED were slightly higher 
for men (3.8 ED visits/patient) than for women (2.9 ED visits/pt). 
Among patients 18 years and younger (table/chart 3), the predominance 
of total ED visits by females was much more striking, with 84% of ED visits 
by females, and 16% by males. Among these younger patients, "per person" 
visits to the ED were higher for women (2.5 ED visits per patient) than for 
men (1.0 ED visits per patient). 
Among all patients 19 years or older (table/chart 4), however, the 
female dominance of ED use was reversed, with males accounting for 54.6% 
of ED visits, and females for 45.4%. On a "per person" basis, the gender 
difference was even more striking, with 5.8 ED visits per male patient, versus 
3.2 ED visits per patient for females. 
Care must be taken in assessing the importance of this male 
predominance in ED use by sickle-cell patients 19 years and older. In fact, 
this male predominance appears on closer examination to be at least partially 
due to a skewing effect by a very small group of patients with very high 
frequency of ED use. When, for example, the three patients with the highest 
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frequency of ED use (two males and a female, accounting together for 119 
ED visits) were temporarily removed from the data set, female predominance 
in use of the ED reappeared (see chart 4a). 
In numbers of admissions and hospital days for all patients, female 
patients predominated as well, again at least partially reflecting their larger 
numbers in the sample (see table/chart 2). Female patients overall accounted 
for 72.6% of all admissions for sickle-cell patients, and 72.5% of hospital 
days, versus 27.4% of admissions and 27.6% of hospital days for males. 
Morover, on a "per patient" basis overall, female patients were admitted more 
frequently (1.42 ad 'its/patient) than males (.94 admits/patient). However, 
average length of hospital stay was similar overall for men (5.9 
days/admission) and women (5.9 days/admission). 
In summary, the sample of sickle-cell patients included 132 patients with 
a mean age of 21 years. There was a striking predominance of young 
patients, with 50% of patients under 20 years of age, and only 4 patients over 
the age of 50 years. Of all hospital use by members of the sample, the largest 
proportion of ED visits was accounted for by patients in the 21-30-year age 
group, and the largest proportion of admissions and hospital days was 
accounted for by patients in the 11-20-year age group. In addition, there was 
a striking predominance of female patients in the sample, with females 
making up 64% of the sample overall. Female patients overall accounted for 
57% of ED visits, 73% of total admissions, and 72% of total hospital days. 
The female predominance in patient numbers and in hospital use was greater 
in younger patients than in older patients. 
f 
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4. Analysis of results by number of ED visits 
See tables 5 and 6, and charts 5 and 6 
The variation in frequency of use of emergency services among sickle¬ 
cell patients in the sample was very wide. It was observed at the outset that 
a small number of patients had visited the ED with very high frequency. For 
example, the five adult patients with the highest ED use had visited the ED 
50 times, 37 times, 32 times, 22 times, and 15 times respectively during the 
study year. Many other patients had visited only once or twice during the 
study year, or not at all. 
In order to study overall hospital use by patients with different levels 
of use of emergency services, the sample of sickle-cell patients (132 patients) 
was stratified into four groups based on number of ED visits during the study 
year. The groups were arbitrarily defined as follows: 
Group 1: No ED visits at all 
Group 2: Between 1 and 5 ED visits 
Group 3: Between 6 and 10 ED visits 
Group 4 11 or more ED visits 
! 
Data were analyzed separately for younger patients and adult patients. 
It is important to note that this division, as well, is based on an arbitrary 
choice, namely, on the choice of 18/19 years of age as the dividing point. 
This division is convenient for the sake of analysis, and offers a simple way 
to ascertain whether the patterns of hospital use are grossly different for 
children and for adults with sickle-cell disease. However, this division may 
not, for example, reflect whether patients in each group are seen on the 
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pediatric or on the adult side of the ED. As will be seen, a number of 
patients in their early 20’s continued to be cared for by the pediatric service. 
The following chart summarizes data on ED visits (for more detail see 
tables 5 and 6): 
Visits to the Emergency Department by Patients at Yale-New Haven 
Hospital from October 1, 1989 to October 1,1990: 
Younger Patients Adult Patients 
(age < = 
Pt. 
18 vr) 
ED visits 
(age > = 
Pt. 
19 yr) 
ED visits 
# # (%) # # (%) 
Group 1 23 0 (0%) 19 0 (0%) 
(no ED visits) 
Group 2 33 62 (50%) 38 81 (27%) 
(1-5 ED visits) 
Group 3 4 30 (24%) 8 60 (20%) 
(6-10 ED visits) 
Group 4 2 33 (26%) 5 156 (53%) 
(11+ ED visits) 
TOTALS 62 125 (100%) 70 297 (100%) 
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a. Younger patients (18 years and younger) 
Among the 62 sickle-cell patients who were 18 or younger (see 
table/chart 5) during the study year, the majority (33 patients) had between 
1 and 5 ED visits, 4 patients had between 6 and 10 visits, and only 2 patients 
had 11 or more visits. The greatest number of visits in this group was by a 
2-vear old female patient, who visited the ED 21 times during the study year. 
Younger patients in groups and 3 and 4, as was expected from the group 
selection criteria, accounted for ED visits out of proportion to their number. 
The 6 patients in these two groups (about 10% of the total group of younger 
patients) accounted together for 63 visits (about 50% of all ED visits by 
younger patients). 
Younger patients who visited the ED frequently were also hospitalized 
more often, and stayed in the hospital a greater number of total days, than 
patients who visited the ED less frequently. Patients in groups 3 and 4 were 
admitted an average of 4.8 and 6.5 times per patient, respectively, compared 
with .3 times per patient among patients in group 1, and 1.2 times per patient 
in group 2. However, average length of hospital stay (as shown in table 5, 
left-most column) was relatively similar for all groups, with an average of 5.1 
days per admission. 
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b. Adult Patients (19 years and older) 
Among the 70 sickle-cell patients who were 19 or older (see table/chart 
6) during the study year, 19 patients did not visit the ED at all, 38 patients 
visited between 1 and 5 times, 8 visited between 6 and 10 times, and 5 
patients visited 11 or more times. The greatest number of visits by an adult 
was by a 30-year old male, who visited the ED 50 times during the study year. 
Adult patients in groups 3 and 4 (ie with 6 or more ED visits) visited 
the ED far out of proportion to their numbers. The 13 patients in these two 
groups (representing about 19% of adults in the sample) accounted for 216 
ED visits, or about 73% of all ED visits by adults. In fact, the 5 patients in 
group 4 alone, though representing only 7% of adult patients, accounted for 
about 53% of all ED visits by adults. 
As with younger patients, adult patients who visited the ED more 
frequently were also hospitalized more often, and stayed in the hospital a 
greater number of days, than patients who visited the ED less often. Adult 
patients in groups 3 and 4 were admitted an average of 3.3 and 3.4 times per 
patient, respectively, compared with .4 times per patient among patients in 
group 1, and .9 times per patient among patients in group 2. 
Average length of hospital stay for all adult sickle-cell patients (as 
shown in table 6, left-most column) was 6.6 days per admission. Patients in 
group 1 (ie patients who had not visited the ED, and thus who were not 
admitted via the ED) had an especially high average length of hospital stay, 
at 10.5 days per admission. Conversely, patients in group 4 (ie those with at 
least 11 visits) had a relatively shorter length of hospital stay, at 4.8 days per 
admission. 
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c. Summary of data on frequent ED visitors 
In summary, the most striking common theme among both younger 
patients and adults was the disproportionate number of total ED visits 
accounted for by small groups of very frequent ED visitors. Among patients 
in groups 3 and 4 (ie those with 6 or more ED visits), 6 younger patients 
(10% of all younger patients) accounted for 50% of all ED visits by younger 
patients, whereas 13 adult patients (19% of all adult patients) accounted for 
73% of ED visits by adults. 
Note that this predominance of ED use by a small group of frequent 
ED users w'as much more marked in adults than in younger patients. Indeed, 
among adult patients, those patients with 6 or more ED visits were greater 
in number (13 adult patients vs. 6 younger patients) and accounted for a 
higher proportion of total ED use (73% of visits by adults vs. 50% of visits 
by younger patients). 
Among both younger patients and adults, patients who visited the ED 
frequently were also admitted more frequently on average, and spent more 
days in the hospital, than patients who visited the ED less frequently. 
5. Analysis of results by month 
See table 7, and charts 7 through 10 
It has been often reported that sickle-cell crisis may be evoked in many 
patients by cold weather, or by rapid changes in temperature. One might thus 
expect that during cold weather that visits to the ED by sickle-cell patients 
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would increase, or that patients would he admitted more frequently. 
Therefore, it was of interest to investigate seasonal variations in hospital use. 
To this end, numbers of ED visits and admissions were calculated for 
each month of the study period, for the group as a whole, as well as for 
younger patients (18 years and younger) and for older patients (19 years and 
older). These were plotted against average daily temperatures for each 
month, as reported by the United Illuminating Company, a local electric 
utility company. The results may be found in table 7 and charts 7 through 10. 
The number of Emergency Department visits and admissions varied 
widely by month. Monthly ED visits during the study period ranged from 19 
to 47 visits, with a mean average of 35.2 ED visits/month. Monthly 
admissions ranged from 7 to 20, with a mean average of 13.7 
admissions/month. 
In order to evaluate these monthly fluctuations in Emergency 
Department visits and admissions, numbers of ED visits and admissions were 
totalled for the four months during the study period when average daily 
temperatures were under 40 degrees F (December, January, February, and 
March), and also for the four months when average daily temperatures were 
above 60 degrees F (June, July, August and September). 
Put briefly, no increases in Emergency Department visits were found 
during colder months of the 1-year study period. As can be seen in table 7, 
numbers of ED visits and admissions were very similar for cold and warm 
months. For all patients, in fact, ED visits during the four "cold" months (142 
ED visits) were actually slightly fewer than in the four "warm" months (150 
ED visits). Numbers of admissions for all patients were also similar during 
"cold" months (60 admissions) and "warm" months (58 admissions). 
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Neither was a seasonal variation in hospital use seen among younger 
patients as group (see table 7, chart 8), nor adult patients as a group (table 
7. chart 9). Numbers of Emergency Department visits and admissions were 
similar during warm and cold months for both younger and adult patients. 
The only case in which a cyclical pattern appears to exist, as seen visually in 
a rising and falling curve, is in admissions for younger patients over the study 
year, with a nadir in a warm month (May) and a peak in a cold month 
(December) (see chart 9). But as remarked, no significant difference was 
found in younger patients’ total admissions over the 4 "cold" and the 4 "warm" 
months. 
It should be remarked here that the method followed here only roughly 
examines the effect of temperature on sickle crisis. Figures were totalled by 
month, and no attempt was made to quantify the increased risk of sickle crisis 
based on the temperature during any individual day, or any time of day. 
In summary, there was wide variation in numbers of Emergency 
Department visit and admissions by month during the study period. However, 
no cyclical or seasonal pattern could be observed, neither in sickle-cell 
patients as a whole, nor in younger patients nor adult patients as groups. The 
present analysis indicates that total ED visits and admissions among sickle-cell 
patients did not increase during cold months. 
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6. Summary of computer survey results 
Visits to YNHH hv patients with sickle-cell disease. 1 
Oct. 1898 to 1 Oct. 1990 
The computer survey identified a total of 132 patients with sickle-cell 
disease, with a mean age of 21 years. Of the 422 visits to the Emergency 
Department accounted for by sickle-cell patients during the study year, 131 
(31.0%) resulted in admission. These 131 ED admissions represented 79.9% 
of the 164 total admissions for the group. Admissions overall lasted an 
average of 5.9 days each. 
Results of the computer survey were analyzed by age, gender, and 
frequency of ED visits, as well as by month. The following findings were 
especially striking: 
a. ) There was a striking predominance of young patients, 
with 50% of patients under 20 years of age, and only 
4 patients over the age of 50 years. 
b. ) There was a striking predominance of female patients 
in the sample, with females making up 64% of the 
sample overall. Female patients overall accounted for 
57% of ED visits, 73% of total admissions, and 72% of 
total hospital days. The female predominance in 
patient numbers and in hospital use was greater in 
younger patients than in older patients. 
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c. ) The most striking common theme among both younger 
patients and adults was the disproportionate number of 
total ED visits accounted for by small groups of very 
frequent ED visitors. Among patients with 6 or more 
ED visits during the study year, 6 younger patients 
(10% of all younger patients) accounted for 50% of all 
ED visits by younger patients, whereas 13 adult 
patients (19% of all adult patients) accounted for 73% 
of ED visits by adults. 
d. ) Among both younger patients and adults, patients who 
visited the ED frequently were also admitted more 
frequently on average, and spent more days in the 
hospital, than patients who visited the ED less 
frequently. 
e. ) There was wide variation in numbers of Emergency 
Department visit and admissions by month during the 
study period. However, no cyclical or seasonal pattern 
could be observed, neither in sickle-cell patients as a 
whole, nor in younger patients or adult patients as 
groups. 
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7. Tables and charts - phase 1 
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B. Phase 2 results 
1.) Where does the patient receive his or her care? 
All 8 of the interviewed patients stated that Yale-New Haven Hospital 
was the place they usually went when they wanted to see a doctor about their 
sickle-cell disease (02). When asked whom they would call first in the event 
of a sickle-cell crisis (03), all 8 patients replied that they would call the 
hematologist they knew from a Yale Hematology Clinic; 6 of the patients 
attended adult hematology clinic, and 2 attended pediatric hematology clinic. 
Four of the adult patients had been seen at other health-care facilities 
in the past year (05): two patients had sought treatment in the Emergency 
Department of a nearby community hospital in New Haven, 3 times and 1 
time respectively. In addition, two other patients had been out of state in the 
past year during a sickle-cell crisis, and had been hospitalized out of state, 
one time each. However, none of the patients had seen a private physician 
(that is, one with his or her own office outside a hospital) in the past year 
(06). 
2.) Patient satisfaction with overall care 
Patients were asked to evaluate the care they received in three areas of 
Yale-New Haven Hospital, the Hematology Clinics, the Emergency 
Department, and the inpatient floors of the hospital (ie while admitted). For 
each of these three areas, patients were asked to give a rating in three topics: 
1) "In general, how well do the doctors ... explain to you what is 
going on with you medically?" 
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2) "In general, how well do doctors ... do as far as taking enough 
time to see you?" 
3) "In general, how well do doctors ... do at treating the pain of your 
sickle-cell crises?" 
Patients were asked to give a rating in each of these topics from among 
the following choices: 1) Poor, 2) Fair, 3) Good and 4) Excellent. In order 
to facilitate comparison of patients’ responses in different hospital areas, 
grades of "excellent" were recorded as a score of "4", "good" as a score of "3" 
and so on. A response of "fair to good" was recorded as "2.5". In addition to 
the answers to individual questions, a combined score was calculated by 
adding together the ratings in the three topics, and then dividing by 3. Thus, 
the combined scores had the same possible range as the answers to individual 
questions, ie from 1 to 4. 
Mean scores in the three topics for the 6 patients treated on the adult 
side of the Clinics, Emergency Department and inpatient floors were as 
follows, with standard deviations shown in parentheses (): 
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Hospital areas: 
Topics: Clinic ED Inpatient floors 
1) Explaining: 3.2 (0.8) 2.2 (1.0) 3.5 (0.5) 
2) Taking 
enough time: 3.0 (0.8) 2.2 (0.8) 3.3 (0.8) 
3) Treating 
pain crisis: 3.3 (0.6) 2.2 (0.8) 3.7 (0.5) 
4) Combined score 3.1 (0.5) 2.2 (0.6) 3.5 (0.5) 
Because the sample size (6) was small, and there was no reason to 
expect that the variances of the scores in the three areas (Clinic, ED and 
admissions) would be different, the Student’s T-test was used to compare 
average scores by the 6 patients treated as adults. 
Patient's scores of quality of patient care in all areas were significantly 
lower for the Emergency Department than they were for the clinic or for the 
floors. As regards "treating pain crisis", for example, the ED received 
significantly lower ratings than the clinic (P<.05) and the inpatient floors 
(P<.005). Overall scores were also significantly lower for the ED than for 
the clinic (P<.()25) and the inpatient floors (P<.005). Differences in scores 
between the clinic and the floors were not statistically significant. 
It can be concluded that patients treated on the adult side of the 
hospital were significantly dissatisfied with the care they received in the 
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Emergency Department compared with the clinics and the floors. Overall 
score for the ED was 2.2, which was closest to "fair". Care in the clinics and 
inpatient areas received higher ratings of 3.1 and 3.5 respectively, which 
translate to between "good" and "excellent". 
With only 2 patients in the sample treated on the pediatric side, it is 
difficult to come to any general conclusions regarding pediatric care. 
However, it is worth noting that both patients gave for the most part scores 
of 4 ("excellent") to the clinics, ED, and floors equally. 
Patients' experiences in three areas of the hospital - clinics, ED and 
inpatient -- will now be discussed separately. 
3.) Experiences with Hematology Clinic 
All six sample patients treated on the adult side of the hospital reported 
generally good long-term relationships with their clinic doctors at the Adult 
Hematology Clinic. Relationships with attending doctors were often of very 
long duration; in fact, one patient had been seeing her clinic attending for 
some decades. Four of the six patients had seen their clinic attending for 5 
or more years. The shortest relationship was 2 years. Five out of the six 
patients gave their clinic attending a rating of "good" or "excellent" in 
"understanding their medical problems" (128). 
In spite of these generally good ratings, 4 out of the 6 patients reported 
that they had had problems obtaining prescriptions at clinic in the past year. 
One of these patients reported that clinic doctors had been prescribing 
Unfortunately, no question specifically addressed the differences in patients’ 
perceptions of their attending physicians and of the hematology fellows, who 
also worked in clinic. 
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generic meperidine instead of the proprietary Demerol, and that the generic 
version did not relieve pain to the same degree. The patient ascribed this 
change to financial reasons: "My doctors at clinic say that Demerol is too 
expensive, and that my medical care [Title 19] won’t cover it". 
The other three patients who reported difficulty in obtaining pain 
medications felt that suspicions of drug-seeking or drug addiction were the 
source of the difficulty. In several instances, patients acknowledged having 
had actual problems around the issues of narcotics in the past, as in this 
quote: 
"If I’m going through a crisis, it can last 4 to 5 days. They used to 
give me 20 Demerol [tablets], and I’d have a few extra. So I’d sell 
them to another patient with sickle-cell disease. I was honest with 
my doctors at clinic - I told [my doctor] myself, but they held it 
against me." 
However, regarding the issue of addiction, the same patient noted that "when 
you’re in pain, you just need something to help you - that’s not addiction. 
They [doctors] have never understood the pain, or experienced it." 
More commonly, patients who experienced difficulty obtaining pain 
medications at clinic felt that they were encountering the suspicions generated 
by other patients, who had abused or sold their pam medications. For 
example, one patient remarked that 
"When I first came to clinic, they [the doctors] thought I was one 
of those people who sell their meds. Once they realized that I 
wasn’t one of those people, everything was OK.' 
Similar echoes can be heard in this remark by another patient: 
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"At first it was definitely slack - it was a problem of people 
abusing pain killers, so the clinic doctors were real tight about 
giving pain killers. Now it’s gotten better, at least for me. But 
other patients are still having problems." 
Thus, these patients felt that establishing a trusting relationship with a 
physician in clinic was possible even if it was made difficult by the presence 
of other patients who abused pain medications. 
One patient described an occasion when he had difficulty obtaining pain 
medications early in the course of a sickle crisis which later was complicated 
by a serious infection: 
"At first, [my doctor] didn’t believe that the pain was so bad. He 
didn't want to give a lot -- this way he remained closer in contact. 
In the end, he was fair." 
Thus, the physician’s reluctance to give prescriptions for large amounts of 
pain medications seemed reasonable to the patient, as a way to stay "closer 
in contact". 
It was possible to have the opposite problem as well, as one patient put 
it: 
"Clinic doctors don’t hesitate to prescribe narcotics. There’s no 
hesitation — sometimes they even push the Demerol on me when 
I feel I don’t need it." 
Patients had a number of suggestions on how they felt clinic should be 
improved: for example, one patient felt doctors in clinic should not stick too 
inflexibly to "certain protocols they have for pain ... there are times when 
they should be more lenient, when a patient really needs it'. Also, the 
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doctors should not be "so hurried". One patient remarked on the very long 
wait before a patient could be seen: "When you come to clinic, you have to 
wait and wait and wait for a doctor to see you. When you’re in pain, the 
waiting is the hard part." 
Overall, patients were generally positive about the care they received 
in adult clinic. As one patient remarked. "Overall, they’re pretty good, the 
doctors I deal with. I like my attending doctor too." 
The two patients treated in the pediatric hematology clinic gave glowing 
reports, such as this one: 
"They are excellent at clinic - when I call, they get everything 
ready for me, my fluid bags and my medications. They even 
arrange everything for me when I go to the ER. They really know 
me and understand my problems." 
Of course, no generalizations can be made about pediatric clinic due to the 
small sample size. 
4.) Experiences with the Emergency Department 
Interviews with six patients who were frequent visitors to the adult side 
of the Emergency Department during the study period revealed considerable 
conflict and anger around issues of pain relief and narcotic analgesics. In 
addition, patients remarked that they often felt neglected or forgotten in the 
hectic atmosphere of the Emergency Department. All six patients reported 
that there was no doctor at the Emergency Department who was responsible 
for their care on an extended basis, from visit to visit. 
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a.) Difficulty obtaining sufficient analgesia 
When asked whether they had had any difficulty obtaining sufficient 
painkiller during visits to the ED in the last year, 5 out of the 6 patients 
replied that they had, and that the reason had been that "doctors did not 
believe that the patient needed more painkiller" (0.20). The frequency of 
this problem was described as "very often" by 3 patients, "fairly often" by 1 
patient, and "only seldom" bv 1 patient. Interestingly, the 3 sickle-cell patients 
who answered that they had had difficulty obtaining painkiller "very often" 
were also the same sickle-cell patients who had visited the ED with the 
greatest frequency during the study period. 
b.) Common themes in the interviews with adult patients 
(1) Incomprehension of sickle pain 
A number of common themes were brought up by patients in the 
interviews. Perhaps the most common was the feeling (cited by 4/6 patients) 
that there was little comprehension of the severity of sickle-cell pain among 
Emergency Department staff. In a particularly illustrative quote, one patient 
asked 
"How can the ER doctors know when someone isn’t in pain? 
Thev don’t understand how much pain sickle-cell patients have." 
In another example, a patient remarked that 
"...sometimes the doctors tell you, ’the pain in your wrists isn’t so 
bad — go home and take some Tylenol.' But I say, ’if I could take 
some Tylenol at home, why would I come in here?’. It really 
makes me mad sometimes." 
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Thus, the patient was angry that appearing in the ED for pain relief was 
apparently not assumed by ED staff to be sufficient evidence that the pain 
could not be handled at home with non-narcotic medications. This feeling 
was echoed by another patient who had had difficulty obtaining sufficient 
pain relief: "I wouldn’t go to the ED if I wasn’t in pain." 
(2) Accusations of drug-seeking and malingering 
Patients frequently reported that they felt accused of drug-seeking, drug 
abuse, or malingering by ED staff (5/6 patients). As one patient put it, "they 
look at you like you're some kind of junkie". The accusation of drug abuse 
could take direct or indirect forms. As an example of a direct accusation, one 
patient noted that "one time a nurse made a smart remark - she said I was 
on drugs, and that I had overdosed [before]". Another patient described a 
direct accusation of drug abuse as follows: 
"They treat you like dirt if they think you’re injecting drugs. They 
accused me of shooting up and carrying drugs on me. I thought, 
now it’s going to be hell getting treated. After that, they gave me 
only one shot [of Demerol], and I couldn’t get a hold of my 
hematologist for more." 
Thus, the patient felt that the accusation of drug abuse was directly connected 
to the withholding of narcotic analgesics. Note that the patient looked to his 
hematologist, that is, to his primary physician from hematology clinic, for help 
in obtaining treatment with narcotic analgesics. 
Indirect accusations of drug-seeking were also described by several 
patients, and appeared to be more subtle. One patient described this type of 
interaction as follows: 
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"People tell you that you’re abusing drugs in a very indirect way - 
- they’ll just hint around the issue for a while. Or they’ll tell you 
about other people who abuse drugs, and make you feel like 
you're being lumped in with them." 
Patients generally were quite taken aback by the accusation of drug¬ 
seeking, which they found to be unwarrented. For example, one patient 
remarked that Tve even been insinuated as being a drug user — no one in 
the ED knows me or cares". This same patient reported that it had been 
necessary to get a "letter of reference" from a hematology fellow attesting to 
the patient’s honesty and documenting the doses of Demerol previously 
needed to treat a crisis. 
Several patients (2/6 patients), however, suggested that doctors were 
justified in some cases in being "careful" about analgesics, as in this remark: 
"Of course, they [the doctors] do try to cut down on painkillers, with all the 
abuse of painkillers going on". Another patient made a very similar remark: 
"There are some people who sell prescriptions, so doctors have to be very 
careful." 
Two patients admitted to having had actual problems with drug use in 
the past. One patient had once attempted to self-medicate sickle pain by- 
injecting a crushed Demerol tablet, and subsequently had a seizure on the 
way to the Emergency Department. Another patient had used "drugs" in an 
unspecified manner some 4 to 5 years previously, but stated that drug use had 
stopped. Both patients maintained that though they were not abusing 
narcotics presently, they felt that lingering suspicions raised by these previous 
incidents continued to obstruct their access to narcotic analgesics. 
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In a particularly interesting comment, one patient described the mode 
by which suspicions about drug-seeking were passed among physicians in the 
Emergency Department: 
"Some ER doctors treat you well. For others, some nurse will tell 
them something about me which changes their attitude completely 
-- a nurse might say, I saw him last week, and I don’t think he’s 
really sick’... Attitudes about me get passed from doctor to doctor, 
so that there are times when no one believes me when I need 
more painkiller. And then I might not be able to reach my 
hematologist, and can’t get the relief I need, and it feels like I’m 
banging my head against the wall." 
Thus the patient felt unable to escape previously aroused suspicions about 
drug-seeking, even when being treated for the first time by a new physician. 
(3) Issues of power and control 
Another important theme which emerged from several of the interviews 
(2/6) was the theme of power relations between physician and patient. One 
patient, for example, made the following remark: 
'There's one female doctor there [at the ED] who feels that she 
decides how much painkiller I get - other people will ask me how 
much I need, but not her". 
Thus, for the patient, the interaction between the patient and the physician 
in this case was centered around the control of medications. In another 
example, a patient who had had difficulty with substance abuse several years 
previously felt that pain medication was being withheld in a punitive fashion: 
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"I need like 125 mg of Demerol and 50 of Vistaril [when I have 
a crisis]. When they won’t give me as much as I need, they’re 
punishing me - I’m there for my condition... They look at me like 
they’re thinking, ’you just want the drugs’". 
This feeling of helplessness and punishment was echoed by another patient, 
who stated, "when they [the doctors] get you in a spot, they can really drive 
the pain in." 
(4) Toradol 
Two patients specifically mentioned the use of Toradol (generic name 
Keterolac), a non-steroidal anti-inflammatory medication. One patient 
reported that it had been tried twice, but had not been effective: 
"it just burned and made me sick in my stomach. I think they [the 
doctors] should have explained to us about it before experimenting 
on us." 
In the case of another patient, the patient believed on one occasion that 
keterolac had been secretly substituted for meperidine, as the patient noticed 
no effect from the injection given. In addition, the patient was suspicious 
because the nurse had not gone to the narcotics room for medication prior to 
the injection. Thus, both patients who reported being treated with keterolac 
felt that this medication was ineffective, and that it was used in a deceptive 
fashion in their cases. 
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It should be noted that an extensive literature search revealed no study 
which documented the effectiveness of keterolac in sickle-cell disease. 
c.) Interviews with 2 patients treated by the pediatric 
service of the Emergency Department 
Only two of the patients who were interviewed had been treated on the 
pediatric side of the Emergency Department. Both of these patients were 23 
years old, and would normally have been triaged to the adult medical service. 
However, they continued to be treated by the pediatric service, where they 
had been seen fo, many years by a special sickle-cell service overseen by 
pediatricians and coordinated by a nurse-practitioner. Both expressed 
reluctance to be transferred to the adult service because of the rushed 
atmosphere they perceived to exist there, as in this quote: 
"[My nurse] has told me that soon I’ll have to go over to the adult 
ER - but the patients on the adult side don’t get the same 
treatment. The doctors over there don’t know me, and they rush 
you through and don’t give you the same attention as on the 
pediatric side." 
Both patients seen by the pediatric service, therefore, were aware that their 
age made it more and more difficult to be retained by the pediatric service 
in the Emergency Department, but persisted in their attempts to avoid what 
they perceived to be a hectic atmosphere on the adult service. 
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d.) Overall impression of patients' experiences with the 
Emergency Department 
The overall impression left by the 6 interviews with patients treated by 
the adult service of the Emergency Department was one of distrust and 
anger. These patients, who had all visited the Emergency Department 
frequently for sickle-cell crisis, felt that suspicions of drug-seeking directed 
against sickle-cell patients were prevalent (though not universal) among their 
physicians in the ED, and that this distrust, transmitted among physicians and 
nurses, made it difficult to receive sufficient narcotic analgesics. It is 
interesting to note that the two patients who were treated by the pediatric 
service were of an age normally treated by the adult service; both expressed 
reluctance to be transferred to the adult service because of the rushed 
atmosphere and lack of personal attention they perceived to exist on the adult 
service. 
It must be understood that whatever basis ED staff had for their 
suspicions of drug-seeking, it could not be argued that frequent visitors to the 
ED did not suffer from very debilitating, serious illness. In fact, the eight 
patients interviewed were admitted to the hospital relatively frequently 
throughout the study year (an average of 3.6 times per patient). In addition, 
all eight patients had had at least two serious complications of sickle-cell 
disease in previous years. Among the eight patients, these complications 
included transient ischemic attacks or cerebrovascular accidents, pneumonias 
or pulmonary infarcts, cholelithiasis, hepatitis B, priapism, cardiac dilatation, 
ischemic heart disease, bony infarcts, pulmonary embolism, vertebral 
osteomyelitis, aplastic crisis, iron overload and transfusion resistance. 
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5.) Experiences on inpatient floors 
The 6 patients who were hospitalized as inpatients on the adult medical 
service during the study period reported generally positive experiences. As 
noted above, patients treated on the adult service gave the inpatient floors a 
combined rating of 3.5, which translates to "good to excellent". Only 2 
patients reported having had any difficulty obtaining sufficient pain relief, and 
both of these patients stated that this problem had occurred only "seldomly". 
One recurrent problem, reported by 2 patients, was that the waiting time in 
the Emergency Department before transfer to an inpatient floor could be 
extended, as long as 3 to 4 hours. Once on the inpatient floors, however, 
patients were generally satisfied with their care. 
Two patients were hospitalized as inpatients on the pediatric service. 
Both were satisfied with the care they received, and neither reported any 
difficulty obtaining adequate pain relief for sickle crisis while admitted. 
6.) Compliance with doctor's orders 
Of the 8 patients interviewed, seven reported that they had been 
advised by their physicians to cut down on activities such as sports and heavy 
work, and all 8 reported that they had been advised to drink large quantities 
of water and to take other steps to avoid sickle crisis. As reported by 
patients, compliance was good, with all 8 patients stating that they tollowed 
their physician’s advice either "always" (5 patients) or "usually" (3 patients). 
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Two patients noted that they occasionally played sports or participated 
in other strenuous activities against which they had advised by their 
physicians, but that playing sports helped them to stay fit and remain "like a 
normal person". Their decision to participate in strenuous activities was a 
personal one, and they did not express any conflict with their physicians over 
it. As one patient put it, 
"I felt that sports helped me, even if it brought on a crisis 
sometimes -- I try to stay active. Strenuous work causes crisis, so 
1 follow doctor’s orders not to do it." 
What was notable, therefore, in patients’ answers to questions about 
compliance was that there was little conflict with their physicians over steps 
to be taken to avoid sickle crisis. Steps such as drinking large quantities of 
water and avoiding strenuous effort, though burdensome at times, were 
generally seen by patients as reasonable. 
7.) Disability 
Of the 8 patients interviewed, all reported that sickle-cell disease had 
had a profound effect on their lives. The effects of the disease were greatest 
on patients’ ability to earn a livelihood; all 8 patients reported that they 
would have liked to "work at a job or business" in the previous year, but that 
sickle-cell disease had prevented them from doing so at some time. Patients 
described the impact of the disease on their ability to work at a job or 
business as "very large" (7 patients) or "large" (1 patient). Of the 8 patients, 
5 were on disability, one was "temporarily out of work', one was not usually 
employed", and one worked part time. 
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Effects of the disease on patients’ ability to continue their education 
were also great. Seven of the eight patients stated that they would have liked 
to "go to school" in the previous year, and all of these 7 patients reported that 
sickle-cell disease had prevented them from doing so at some time. When 
these 7 patients were asked to describe the impact of the disease on their 
ability to continue their education, 4 patients responded with "very7 large", one 
with "large", one with "moderate", and one with "small". Of the total 8 
patients, one had completed a college education. 3 had started college but not 
graduated, and 4 had graduated from high school. 
In contrast, the impact of sickle cell disease on patients' ability to keep 
house and do household chores did not appear as great. Five of the 8 
patients reported that their illness had prevented them from "keeping house" 
at some time in the previous year, but the impact of the illness in this area 
was judged to be "small" or "moderate" by 4 out of these 5 patients. 
Patients mentioned periodic absences due to sickle crisis as a reason for 
their difficulty with employment and with education, as in the following 
remark: 
"I can’t get the type of job I want - I need more training, but I 
miss classes when I get sick, and I get behind." 
Patients expressed frustration that in spite of periods of relatively good 
health, recurrent pain crisis made regular employment or education very 
difficult. This frustration was typified in the following remark: 
"I always wanted to be like my sister and brother, but I couldn't - 
- I’m much more dependent on my parents than they are. I really 
want to start working, so that I can be more on my own. It’s hard 
when you’re always sick." 
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In general, therefore, patients considered themselves to be significantly 
disabled, especially in employment and education. Painful sickle crisis was 
not just a periodically troublesome phenomenon in their lives, but a source 
of more general difficulty. Though psychological issues of self-esteem and 
dependence were not explored more deeply in the interviews, remarks such 
as the one just cited make it clear that difficulties with employment and 
education have wide-ranging psychological ramifications. 
It should be pointed out that the patients interviewed were all frequent 
visitors to the Emergency Department, and that their experieneces with 
disability may not reflect the disability of sickle-cell patients in general. 
8.) Access to medical care 
Patients reported generally good access to medical care. Of the 8 
patients interviewed, 7 had Medicare or Title 19 assistance, and 1 had 
insurance with a private insurer. Yale-New Haven Hospital was the medical- 
care facility preferred by all 8 patients; none had been forced to seek care 
at Yale because financial constraints had prevented them from being seen 
elsewhere. 
Two of the patients had had difficulty in the past year paying for 
medical care. In one case, a dispute with a private insurance company led to 
difficulty paying, and in another case, a patient whose Medicare paid 80% of 
hospital bills had difficulty paying the remaining 20%. Only one patient 
reported that a financial difficulty had actually impaired care. In this case, 
the patient reported that because Title 19 would not pay for proprietary 
Demerol, it was necessary to purchase the less expensive generic version. 
Meperidine. Though the patient found generic meperidine to be ineffective, 
the effect of this substitution was still judged to be "mild". 
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These findings about access to health care among frequent visitors to 
the Emergency Department will be important in considering the patient- 
physician relationship. It is important to emphasize in any case that it was 
not generally financial pressure which forced patients to seek care at YNHH 
rather than at nearby community hospitals. Conversely, from the hospital’s 
standpoint, it is important to note that even though only one of the eight 
patients interviewed was working regularly (part-time), all had some form of 
insurance, primarily governmental (Title 19. Medicare or both for 7 of the 8 
patients). Thus, care to these frequent ED visitors was not being supplied 
'gratis' by the hospital. 
9.) Patients' overall perspective on the medical care system 
In the final question of the interview, patients were asked to answer the 
following question, designed to assess overall perspective on the medical care 
system: 
Which of the following statements comes closest to expressing 
your overall view of the American health care system? (lg) 
1) (Poor) The American health care system has so much 
wrong with it that we need to completely rebuild it. 
2) (Fair) There are some good things in our health care 
system, but fundamental changes are needed to make it 
work better. 
3) (Good) On the whole, the health care system works 
pretty well and only minor changes are necessary to make it 
work. 
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Perhaps somewhat surprisingly, patients appeared to have a generally 
favorable perspective on the medical care system. Of the eight patients 
interviewed, five patients answered "3", and three patients answered "2”. Thus 
the majority of these patients, with their life-long exposure to the health care 
system, remained convinced that "the health care system works pretty well 
and only minor changes are necessary to make it work". 
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V. Discussion 
The unifying hypothesis of the present study, first presented in the 
"Introduction", may now be examined in light of the study’s results. The 
hypothesis posits that a small subset of sickle-cell patients with especially 
severe symptoms becomes known to the Emergency Department staff as 
visiting the ED frequently and requiring large doses of narcotic analgesics for 
painful crisis. Irrespective of the actual prevalence of drug dependence 
among patients, suspicions of drug dependence may arise, leading to a 
tendency among ED physicians to limit the prescription of narcotic analgesics 
for sickle-cell patients in general. Underprescription of pain medication may 
lead to requests for additional pain medication by patients, or to repeat ED 
visits, and thus in turn to escalating suspicions of drug-seeking among ED 
staff. In this way. suspicion of drug-seeking among ED staff and frustration 
at lack of pain relief among patients may begin to fuel one another in a 
continuing circle. 
The present study aimed to investigate this hypothetical circle at several 
points, and to gather the information necessary to organize management 
interventions to interrupt it. Therefore, the first task at hand was to survey 
the ED and other hospital services for use by patients with sickle-cell disease. 
A computer survey identified all visits to the ED by sickle-cell patients over a 
one-vear period (1 October 1989 to 1 October 1990). 
The computer survey identified a total of 132 patients with sickle-cell 
disease, with a mean age of 21 years. Of the 422 visits to the Emergency 
Department accounted for by sickle-cell patients during the study year, 131 
(31.0%) resulted in admission. These 131 ED admissions represented 79.9% 
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of the 164 total admissions for the group. Admissions overall lasted an 
average of 5.9 days each. 
Results of the computer survey largely confirmed the hypothesis that 
small numbers of very frequent visitors to the Emergency Department 
accounted for a disproportionate number of visits. Among patients with 6 or 
more ED visits during the study year. 6 younger patients (10% of all younger 
patients) accounted for 50% of all ED visits by younger patients, whereas 13 
adult patients (19% of all adult patients) accounted for 73% of ED visits by 
adults. These results are consonant with previous studies of ER utilization by 
"frequent visitors" with sickle-cell disease (129). 
Results of the interviews with 6 adult patients who visited the adult 
medical service of the Emergency Department frequently (6 or more times 
during the study period) confirmed the hypothesis that considerable conflict 
between patients with sickle-cell disease and physicians may develop over 
issues of drug-seeking and drug dependence, especially in the Emergency 
Department. Five of the six patients reported that they had experienced 
difficulty obtaining sufficient pain relief during crisis at some time in the last 
year, because "doctors did not believe that the patient needed more 
painkiller". Patients reported that they felt that ED staff did not comprehend 
the pain they experienced during crisis. In addition, patients frequently felt 
accused by ED staff, directly or indirectly, of drug-seeking or drug abuse. 
These problems were not reported by patients to the same degree with the 
hematology clinics or with the inpatient floors. 
Two of the 8 patients interviewed, though both 23 years old, continued 
to be seen by the pediatric service. These two p bents gave equally high 
ratings to the pediatric ED, hematology clinic ana inpatient floors. Though 
their number is too small to permit generalizations, it is interesting to note 
129 See, for example. Vichinsky (1982), p.329. Powers (1986). Also of interest are 
Pierce (1990) and Selbst (1990). 
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thai both patients expressed reluctance to be transferred to the adult medical 
service of the Emergency Department, where they felt that a rushed 
atmosphere prevailed, judging from conversations with adult sickle-cell 
patients. It is important to note that pediatric sickle-cell patients at YNHH 
are cared for by a special sickle-cell service overseen by pediatricians and 
coordinated by a nurse-practitioner. 
Time considerations did not permit interviews with sickle-cell patients 
who visited the Emergency Department a moderate amount, for example, 
between 1 and 5 times per year. These patients represent the great majority 
of patients in the community with sickle-cell disease, and it would be very 
useful to compare their experiences in the Emergency Department with those 
of more "frequent visitors". As it is, it is not known whether conflicts which 
develop between ED staff and ’frequent visitors" also affect the care received 
by the great majority of sickle-cell patients. Follow-up studies will investigate 
this hypothesis. However, it is reasonable to suppose that conflicts with these 
"frequent visitors" may color perceptions among ED staff of sickle-cell 
patients in general. 
Patients reported that the physicians who saw them in hematology clinic, 
namely, hematology fellows and attendings, had a pivotal role in managing 
their care. Patients described long-term relationships with their hematology 
attendings (from 2 years to decades), and reported generally positive 
experiences in hematology clinic. Physicians from hematology clinic 
frequently visited patients when they sought care in the Emergency 
Department, and often interceded for patients in assisting them to obtain 
adequate pain relief in the Emergency Department. 
The Emergency Department physicians with whom patients described 
the most conflict were almost universally members of the hospital housestaff. 
In this context, it is important to note that the frequently exhausted 
housestaff bear the brunt of caring for patients on the front lines , and are 
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most directly subject to the frustrations of dealing with patients one-on-one. 
At the same time, they necessarily have limited experience in dealing with 
knotty issues such as possible drug-seeking and dissembling by patients, In 
addition, it is reasonable to suggest that housestaff, as young physicians, may 
be uncomfortable in discovering the acute limitations of their profession in 
curing the sick (B0). In all these respects, the experience of housestaff is in 
contrast with that of attending physicians (and, for that matter, hematology 
fellows), who are somewhat protected from the stresses of daily life in the 
ED, and who may be more comfortable dealing with the uncertainty and 
limitations of clinical medicine. 
It should be noted that Yale-New Haven Hospital is the only medical 
facility in its area with a significant experience and expertise in treating 
hematological diseases such as sickle-cell disease. The closest academic 
hematology training programs outside of YNHH are in New York City, 
Boston, or Farmington, Connecticut, all a considerable distance from New 
Haven. Though patients in crisis in the New Haven area could also seek care 
at nearby community hospitals, few of the patients interviewed actually did. 
In fact, all 8 of the interviewed patients denied that they would have 
preferred to be seen in some other hospital. This situation might have been 
different in a larger city, in which patients who were dissatisfied with their 
care in one Emergency Department could seek care at a variety of other 
Emergency Departments at hospitals with expertise in hematology. 
130 See esp. Mechanic (1%8) on issues of housestaff vs. attending physicians. 
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Vi. Suggestions for improving care of sickie-cell disease 
A. Genera] considerations 
From the standpoint of the Emergency Department, sickle-cell disease is 
both similar to a number of other illnesses, and entirely unique. For 
example, sickle-cell disease might be compared to other chronic, debilitating 
illnesses with periodic exacerbations, such as asthma, diabetes, hemophilia, 
migraine headaches or lower back pain. In each of these illnesses, as in 
sickle-cell disease, patients may visit the Emergency Department with high 
frequency over many years, and may present difficult problems of diagnosis 
and treatment. However, sickle-cell disease distinguishes itself from these 
illnesses by its intractability, its severe pain symptoms requiring treatment 
with narcotic analgesics, and in the constant possibility of life-threatening 
complications with each pain crisis. Thus. Emergency Department treatment 
of sickle-cell disease faces relatively unique difficulties. 
A number of possible steps might contribute to alleviating the present 
situation of tension and conflict in the Emergency Department. Any program 
to address the issue of acute care of sickle-cell patients must consider the 
following points: 
1) Though the literature suggests that the great majority of sickle-cell 
patients do not become dependent on pain medications, drug¬ 
seeking and drug dependence are possible among patients with 
sickle-cell disease, given the chronic nature of sickle pain and the 
need for narcotic analgesics. 
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2) Patients with sickle-cell disease are often significantly disabled, 
especially in employment and education, and have an increased 
prevalence of psychosocial difficulties. 
3) The possibility of serious medical complications exists during every 
painful crisis. Early detection of complications such as 
osteomyelitis, for example, may greatly reduce final morbidity and 
shorten the hospital course. 
B. Suggestion: better coordination of care for sickle-cell patients 
For all these reasons, coordination of the care of each patient with 
sickle-cell disease - in the psychological, psychosocial, and medical realms - 
is pivotal. At present, hematology fellows and attendings coordinate the care 
of individual sickle-cell patients in the medical realm, but do not have the 
resources coordinate care for the patient in the Emergency Department, nor 
to coordinate psychological and psychosocial aspects of care. Sickle-cell 
patients who seek care at the Emergency Department on a given day may be 
able to speak with their primary hematology attending, but may also have to 
be seen by whichever of the many hematology attendings and fellows is on 
call that day. At present, there is no one person acquainted with sickle-cell 
patients over the long term, who is able to act as a sort of "central 
clearinghouse" in the management of their care. 
One model for coordinating the care of patients with sickle-cell disease 
is close at hand, and already operating on the pediatric service. Among 
pediatric sickle-cell patients, care is organized by a special sickle-cell service 
overseen by pediatricians and a coordinated by a nurse-practitioner. Within 
this system, the special needs of sickle-cell patients can be addressed in an 
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organized fashion, in the outpatient hematology clinics as well as in the 
Emergency Department. 
C. Suggestion: Management Protocols for pain management 
At the level of the Emergency Department, the use of individualized 
management protocols would assist in standardizing the care of sickle-cell 
patients who frequently utilize emergency services, and in reducing confusion 
and conflicts among different services over treatment of individual patients. 
Such individualized management protocols, drawn up in consultation with 
each patient and his or her hematologist, and updated as needed, would 
provide a short summary of the patient’s history, specify the type and starting 
doses of analgesics to be given for sickle-cell crisis, and list the names and 
telephone numbers of physicians responsible for each patient’s care. Nurses 
and house-staff would be instructed to consult the treatment protocol prior to 
the initiation of any therapy for sickle-cell patients presenting for pain, and to 
contact the patient’s primary physician during each ED visit. 
In fact, the use of such management protocols has been sporadically 
attempted in the Emergency Department of Yale-New Haven Hospital. 
Approximately two years ago (ie approx. 1989), according to ED staff, 
management protocols emphasizing the use of oral pain medications and 
limiting the use of IM injections were instituted for several of the most 
frequent ED visitors with sickle-cell disease. However, as described by ED 
staff, such protocols were unsuccessful in reducing patients’ requests for 
medication and repeat visits for pain relief. This lack of success was 
attributed to the difficulty in enforcing such protocols, due to the fragmented 
nature of care for sickle-cell patients and the day-to-day changes in the 
hematologist on call. Thus, from the standpoint of ED staff, the key factor in 
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the failure of such management protocols was the lack of a collective will to 
enforce them, among ED staff and members of the Hematology Section. 
It is also possible, in the hectic atmosphere of the Emergency 
Department, that confusion over when and where to find such management 
protocols may have contributed to their failure. One approach to this 
problem would be to program the ED computer system to print a copy of the 
management protocol at the time that each sickle-cell patient registers. 
A pivotal point in designing a program to coordinate the care of sickle¬ 
cell patients is that the object is improved care, and not merely decreased use 
of IM narcotic pain medications or decreased numbers of repeat visits. It is 
imperative that patients in pain crisis receive adequate analgesia. The design 
of a successful program will involve not only ED physicians, hematologists, 
and nurses, but most importantly, the patients themselves. As such, the 
design of each management protocol should take place with active 
participation by the patient, in order to make the protocol a part of 
therapeutic alliance, rather than an obstacle to receiving pain relief. 
As was discussed in the literature review, success with management 
protocols in reducing conflicts over drug-seeking and in reducing frequency of 
ED visits has been reported in several studies at other institutions. In 
Powers’ study (1986), 5 men with sickle-cell disease were identified as chronic 
ED users; with these 5 patients, a management protocol was associated with 
a reduced total number of ED visits (from 163 to 56 in 6-month periods 
before and after institution of the program), reduced mean length of ED stay, 
and reduced use of parenteral meperidine, as well as increased satisfaction 
with care among both patients and ED staff. In Vichinsky et al’s study 
(1982). a multidisciplinary, comprehensive pain program, which included a 
management protocol for treatment of pain, was associated with a 58% 
reduction in Emergency Department visit and a 44% decrease in pain-related 
hospitalizations in 10 patients with sickle-cell disease. 
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Management protocols drawn up even for a small subset of sickle-cell 
patients at Yale-New Haven Hospital could have a large impact on their care. 
Data from the present study indicate, for example, that only 5 patients at 
Yale-New Haven Hospital accounted for nearly 53% of all ED visits by 
sickle-cell patients over the study year. Thus, management protocols drawn 
up for these 5 patients, if consistently and humanely applied, could reduce 
confusion and conflict in over half of the 420-some visits to the ED by sickle¬ 
cell patients over the course of a typical year. One may be confident that 
reduction in conflict over the treatment of these five "frequent visitors" will 
result in improved care for other sickle-cell patients as well. 
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VIII. Appendix: Survey Questions 

Sickle-Cell Project -- Douglas Fleming, Yale Medical Student 
Revision date: 2 February 1991 
Check when entered into the computer: o 
Face Sheet for Interviews with Patients 
Patient name code: Gender: Age: 
Sent letter? Yes / No 
Phone number code: 
On hand: 1) extra pencils 2) watch 
Check: 3) "Do not disturb" sign 4) pagination 5) sent letter 
6) visit-list or chart for confirmation of sickle disease 
Date and time of first attempt at phone contact: 
o Successful, did interview 
o Reached patient, but pt asked to be called later 
(will call back on date: time: 
o Reached pt, but pt did not want to be interviewed 
o No answer o Busy 
Date and time of second attempt at phone contact: 
o Successful, did interview 
o Reached patient, but pt asked to be called later 
(will call back on date: time: 
o Reached pt, but pt did not want to be interviewed 
o No answer o Busy 
and time of third attempt at phone contact: 
o Successful, did interview 
o Reached patient, but pt asked to be called later 
(will call back on date: time: 
o Reached pt, but pt did not want to be interviewed 
o No answer o Busy 
Date and time of fourth attempt at phone contact: 
o Successful, did interview 
o Reached patient, but pt asked to be called later 
(will call back on date: time: 
Reached pt, but pt did not want to be interviewed 
No answer o Busy 
o 
o 
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Sickle-Cell Project — Douglas Fleming, Yale Medical Student 
Faculty advisor: Joel Rappeport, MD 
Survey of Patients with Sickle Cell Disease: 
What questions will be asked. 
Hello, my name is _, and I'm calling from Yale Medical 
School. We are doing a survey of people with Sickle-cell Disease 
who go to Yale-New Haven Hospital, regarding their experiences with 
the health-care system. I'd like to ask you some guestions about 
your health experiences and medical care. You are free to answer 
or not to answer — your participation is entirely voluntary, and 
will not affect the care you receive. Would you be willing to 
spend a few minutes answering some guestions? 
(If patient agrees) First, I will ask some general questions 
about your experiences with health care, and then I will ask you 
some questions about your last visit to Yale-New Haven Hospital. 
All of your answers will be strictly confidential. This means that 
none of your doctors or other hospital staff will be able to find 
out how you answered any question. Also, you can decide at any 
time not to answer any question, or to stop answering questions 
altogether. The interview will last about 20 minutes. 
(Numbers in parentheses indicate the question number of the 
corresponding question in the 1986 National Survey of Access to 
Health, Principal investigator Howard E. Freeman, #8981. Or, see 
a report of the study's results in Free, H.E., Blendon, R.J. et al, 
"Americans Report on Their Access to Health Care" in Health 
Affairs. Spring 1987, Vol. 6, no. 1, 6-18) 
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*** Q.1 Would you say your health, in general, now is.... (1) 
1) Poor 2) Fair 3) Good 4) Excellent 
<<<<< Where does the pt receive care? >>>> 
*** Q. 2 Is Yale-New Haven Hospital the place where you usually go 
when you want to see a doctor (about your sickle-cell 
disease in general)? 
1) Yes 2) No 
*** Q . 3 Which doctor would you usually call or go to first when 
you have a sickle-cell crisis? 
1) A doctor from Yale adult hematology clinic 
2) A doctor from Yale Pediatric heme clinic 
(Dr. Pearson and Suzanne et al) 
3) a doctor from a clinic at Saint Raphael's Hosp. 
4) a doctor from a clinic at Bridgeport Hosp. 
5) a doctor from a clinic at Hill Health Center 
6) A private doctor 
7) An HMO 
8) Other: _ 
9) YNHH Emergency Room 
10) Some other Emergency Room (which one?_) 
*** Q. 4 Is your sickle-cell disease followed over time by a 
hematologist or hematologists, that is, by a doctor who 
specializes in blood diseases? 
a) 1) Yes 2 ) No 
b) (if YES) Where does this hematologist work? 
1) Yale adult hematology clinic 
2) Yale pediatric hematology clinic 
Suzanne et al) 
(Dr. Pearson, 
4) Saint Raphael's 
5) Bridgeport / 
6) Hill Health Center / 
3) A hematologist in private practice 
own office) 
(in his or her 
> 
4) A hematologist working with an HMO < 
\ 5) Other hematologist 
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*** Q. 5 Is there any other hospital or clinic where you have gone 
for medical care of your sickle-cell disease in the last 
year, that is, since (present month) of last year? 
a) 1) Yes 2) No 
b,c) (If YES) Which one is that? (circle all that apply) 
1) Saint Raphael's 
2) Bridgeport 
3) Hill Health Center 
4) Other hosp. 
5) Other hosp. 
d) How many times have you been seen at this hosp/clinic (s) in 
the past year? 
Q.6 Have you seen a private doctor (in his own office, not in 
a hospital) about your sickle-cell disease in the past 
year ■p 
a) 1) Yes 2) No 
b) (If YES) Where does he or she practice? 
c) (If YES) How many times have you seen this private doctor in 
the past year? 
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<<<< Hematology Clinic >>>> 
*** Q.7 a) Have you been to the hematology clinic (pedi or 
adult) at YNHH in the past year, that is, since 
January of last year? 
Y/N 
b) Were you seen in the pediatric or the adult hematology clinic? 
Pedi / Adult 
c) When was the last time you went to Hematology Clinic at Yale, 
approximately? _ 
(if pt has not been at YNHH hematology clinic (adult or pedi) in 
the past year, skip to the next section) 
*** Q.8 When you visit the hematology clinic at Yale, is there 
one particular clinic doctor who manages your care as 
your primary doctor? (23b) 
a) 1) Yes 2) No 3) Not applicable 
b) (If Yes) How long has this doctor been seeing you in clinic? 
years/months/weeks 
c) (If YES) How well does this doctor understand your medical 
problems? 
1) Poor 2) Fair 3) Good 4) Excellent 
*** Q.9 In general, how well do the doctors in clinic explain to 
you what is going on with you medically? 
1) Poor 2) Fair 3) Good 4) Excellent 
*** Q.10 In general, how well do the doctors in clinic do as far 
as taking enough time to see you? 
1) Poor 2) Fair 3) Good 4) Excellent 
*** Q.ll In general, how well do doctors in clinic do at treating 
the pain of your sickle-cell crises? 
1) Poor 2) Fair 3) Good 4) Excellent 

Question 
*** Q.12 
a) 
e) 
*** Q.13 
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In the past year, when you have visited the Hematology 
Clinic at Yale, have you had any difficulty obtaining a 
prescription for all the painkiller you needed? 
1) Yes 2) No 3) N/A 
(If YES) What have been the sources of the difficulty? 
(check all that have been sources of 
difficulty in the past year) 
b) Financial reasons — pt could not afford to be seen 
(Y/N) 
c) Doctors did not believe that pt needed more 
painkiller (Y/N) 
d) Other reason for not receiving painkiller (Y/N) 
(If YES to a) ) In the past year, how often have you 
experienced this difficulty obtaining painkillers in 
clinic? 
1) only seldomly 2) Fairly often 3) Very often 
Explain (comments on clinic experiences): 
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<<<<< Emergency Room >>>>>> 
*** Q.14 a) Have you been to the Emergency Room at YNHH (pedi 
or adult) at YNHH in the past year, that is, since 
January of last year? 
Y/N 
b) (If YES) Were you seen on the pediatric or the adult side of 
the Emergency Room? 
Pedi / Adult 
c) When was the last time you went to the ER at Yale, 
approximately? _ 
(if pt has not been at YNHH ER (adult or pedi) in the past year, 
skip to the next section) 
*** Q.15 When you visit the Emergency Room at Yale, is there one 
particular emergency room doctor who manages your care as 
your primary doctor? (that is, one who works primarily in 
the ER, not someone, for example, from hematology clinic 
who comes down to the ER to see you) (23b) 
a) 1) Yes 2) No 3) Not applicable 
b) (If Yes) How long has this doctor been seeing you in the 
Emergency Room? 
years/months/weeks 
c) (If YES) How well does this emergency room doctor understand 
your medical problems? 
1) Poor 2) Fair 3) Good 4) Excellent 
*** Q. 16 (If patient has a relationship with a Yale clinic doctor 
— see answer to Q.4) 
When you visit the ER at Yale, how often does your doctor 
from the hematology clinic come to see you in the ER? 
0) N/A 
1) Never 2) Sometimes 3) Usually 4) Always 
*** Q. 17 In general, how well do the doctors in the Emergency Room 
explain what is going on with you medically? 
1) Poor 2) Fair 3) Good 4) Excellent 
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*** Q. 18 In general, how well do the doctors in the Emergency Room 
do as far as taking enough time to see you? 
1) Poor 2) Fair 3) Good 4) Excellent 
*** Q.19 
*** Q.20 
a) 
b) 
c) 
d) 
e) 
In general, how well do doctors in the emergency room do 
at treating the pain of your sickle-cell crises? 
1) Poor 2) Fair 3) Good 4) Excellent 
In the past year, when you have visited the Emergency 
Room at Yale, have you had any difficulty obtaining a 
prescription for all the painkiller you needed? 
1) Yes 2) No 3) N/A 
(If YES) What have been the sources of the difficulty? 
(check all that have been sources of 
difficulty in the past year) 
Financial reasons — pt could not afford to be seen 
(Y/N) 
Doctors did not believe that pt needed more painkiller 
(Y/N) 
Other reason for not receiving painkiller (Y/N) 
In the past year, how often have you experienced thi 
difficulty obtaining painkillers in the Emergency Room. 
1) only seldomly 
Explain 
2) Fairly often 3) Very often 
ER experiences): *** Q.21 (comments on 
o
 
to 
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<<<< Inpatient care >>>> 
*** Q.22 a) Have you been admitted to the hospital at YNHH for 
sickle-cell disease in the past year, that is, 
since January of last year? 
Y/N 
b) Did you stay on the pediatric wards, or on the adult wards? 
Pedi / Adult 
c) When was the last time you were admitted at Yale-New Haven 
Hosp., approximately? _ 
(if pt has not been admitted at YNHH in the past year, skip to the 
next section) 
*** Q.23 In general, 
the doctors 
on with you 
when you are admitted at YNHH, how well do 
in the hospital explain to you what is going 
medically? 
1) Poor 2) Fair 3) Good 4) Excellent 
*** Q. 24 In general, when you are admitted, how well do the 
doctors in the hospital do as far as taking enough time 
to see you? 
1) Poor 2) Fair 3) Good 4) Excellent 
*** Q. 2 5 In general, when you are admitted, do doctors and nurses 
in the hospital do well at treating the pain of your 
sickle-cell crises? 
1) Poor 2) Fair 3) Good 4) Excellent 
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*** Q.26 In the past year, when you have admitted at Yale-New 
Haven Hospital, have you had any difficulty obtaining a 
prescription for all the painkiller you needed? 
a) 1) Yes 2) No 3) N/A 
(If YES) What have been the sources of the difficulty? 
(check all that have been sources of 
difficulty in the past year) 
b) Financial reasons — pt could not afford to be seen 
(Y/N) 
c) Doctors did not believe that pt needed more painkiller 
(Y/N) 
d) Other reason for not receiving painkiller (Y/N) 
e) In the past year, how often have you experienced this 
difficulty obtaining painkillers while admitted overnight 
in the hosptal? 
1) only seldomly 2) Fairly often 3) Very often 
*** Q.27 Explain (comments on experiences while admitted): 

Question List Page 11 Revision date: 2 February 1991 
<<<<<< Compliance >>>>> 
*** Q.28 Have your doctors advised you to cut down on activities 
such as sports or heavy work because of your sickle-cell 
disease? (68f) 
a) 1) Yes 2) No 
4-1
 
H
 
d
 
YES) Are you following the doctor's instructions? 
1) 
2) 
3) 
4) 
hardly ever or not at all 
sometimes 
usually 
always 
*** Q.29 Have your doctors advised you to drink a lot of water or 
take other steps to avoid sickle crises? (adapted from 
6 9a) 
a) 1) Yes 2) No 
b) (If YES) Are you following the doctor's instructions? 
1) 
2) 
3) 
4) 
hardly ever or not at all 
sometimes 
usually 
always 
*** Q.30 In general, do you follow the recommendations given to 
you by your doctors? 
1) 
2) 
3) 
4) 
hardly ever or not at all 
sometimes 
usually 
always 
*** Q.31 (open question) Why or why not? (and in which ways) 

Question 
*** Q.32 
a) 
b) 
c) 
d) 
e) 
f) 
g) 
h) 
*** Q.3 3 
*** Q.34 
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<<<<< Disability >>>> 
In the last year, that is, since (this month) last year, 
has sickle-cell disease prevent you from... 
Working at a job or business? (70b) 
1) Yes 2) No 3) N/A 
(If YES) How great an impact has sickle-cell disease had 
on your ability to work at a job or business? 
1) small 2) moderate 3) large 4) very large 
keeping house? (70d) 
1) Yes 2) No 3) N/A 
(If YES) How great an impact has sickle-cell disease had 
on your ability to keep house? 
1) small 2) moderate 3) large 4) very large 
Going to school? (70f) 
1) Yes 2) No 3) N/A 
(If YES) How great an impact has sickle-cell disease had 
on your ability to go to school? 
1) small 2) moderate 3) large 4) very large 
Carrying out your normal activities in any way? (70j) 
1) Yes 2) No 
(If YES) How great an impact has sickle-cell disease had 
on your ability to carry out your normal activities? 
1) small 2) moderate 3) large 4) very large 
Are you currently.... (83a) 
1) employed full time 
2) employed part time 
3) temporarily out of work 
4) retired 
5) not usually employed 
6) on disability 
7) keeping house/homemaker 
8) other (specify:_ 
<<<<<<<< Pain medication >>>>>>> 
a) During the last year, how many months out of the 
year have you needed to take at least some pain 
medication (for sickle-crisis or for between-crisis 
pain)? 
(answer from 1 to 12) 
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b) (Pain leds, cont'd) In the past year, how often have you 
needed pain medication at home. when you are not in the 
hospital? 
1) Never or hardly ever 
2) Occasionally (once a month or several months) 
3) Fairly frequently (several times per week or 
several weeks) 
4) All or most of the time (most days) 
c) (If yes to b) When you have pain, which pain medication 
do you usually actually take for the pain you have at 
home? 
(drug, dose and route) _ 
d) (If yes to b) Which pain medication works best for this 
pain you have at home? (ie, which pain medication would 
you prefer to get?) 
(drug, dose and route) _ 
e) When you have a bad sickle-cell crisis, which pain medication 
do you prefer to get (and how much): 
(drug, dose and route) 
f) When you have sickle-cell pain crisis, how effective is FV 
narcotic medication in stopping the pain you feel? 
0) Not effective at all 
1) a little effective 
3) moderately effective 
4) very effective 
(record N/A if pt has not tried this method) 
g) When you have sickle-cell pain crisis, how effective is oral 
narcotic medication in stopping the pain you feel? 
0) Not effective at all 
1) a little effective 
3) moderately effective 
4) very effective 
(record N/A if pt has not tried this method) / 
h) When you have sickle-cell pain crisis, how effective is non¬ 
narcotic medication in stopping the pain you feel? 
0) Not effective at all | 
1) a little effective 
3) moderately effective 
4) very effective 
(record N/A if pt has not tried this method) 
i) comments on pain medication: 
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<<<<<<< Access >>>>> 
*** Q.35 In general, would you prefer to go somewhere else other 
than Yale-New Haven Hospital ER or clinic to receive your 
care? (32a) 
a) 1) Definitely yes 2) Perhaps 3) No 
b) (for YES and PERHAPS only) Where would you have preferred to 
go? (32B) 
c) (for YES and PERHAPS only) Why didn't you go there? (32e) 
code answer: (all that apply) 
1) Financial — couldn't afford someplace else 
2) Transportation 
3) Health insurance or HMO covers visits only to YNHH 
4) Regular doctor/HMO etc was not seeing patients 
5) Referred by some other provider 
6) Other reason 
*** Q.36 
a) 1) 
How much difficulty have you had in the past year paying 
for your medical care at YNHH? 
No difficulty 2) Some difficulty 3) A lot of difficulty 
b) (If 2 or 3) Why was that? 
code answer: 
1) Financial -- Had no insurance, couldn't afford payments 
for medical care 
2) Financial — Had health insurance or HMO, but this did 
not cover all costs 
3) Other (will add codes as appropriate) 
*** Q.37 
a) 
b) 
*** Q.38 
In the past year, was there any time when the costs of 
medical care prevented you from getting all the care you 
needed (or felt you needed) at YNHH? 
1) Yes 2) No 
(If YES) How much of an effect do you think this had 
the care you received? 
1) mild effect 2) Strong effect 
Explain (open guestion): 
3) Severe effect 

Question List Page 15 Revision date: 2 February 1991 
<<<<<< BACKGROUND >>>>>> 
*** Q. 39 What is the highest year in your education which you have 
completed? (eg, in elementary school, high school, or 
college) (81 ) 
0) None 
1) Elementary 1 year 
2) 2 years 
3) 3 years 
4) 4 years 
5) 5 years 
6) 6 years 
7) 7 years 
8) 8 years 
9) High school 9 years 
10) 10 years 
ID 11 years 
12) H.S. grad 12 years 
13) College 13 years 
14) 14 years 
15) 15 years 
16) College grad. 16 years 
17) Some graduate school 
18) Graduate or professional 
*** Q.40 What is your marital st 
1) Single — 
2) married 
never married 
3) divorced 
4) widowed 
or separated 
<<<< Overall Perspective >>>> 
*** Q.41 Which of the following statements comes closest to 
expressing your overall view of the American health care 
system? (lg) 
1) (Poor) The American health care system has so much wrong with 
it that we need to completely rebuild it. 
2) (Fair) There are some good things in our health care system, 
but fundamental changes are needed to make it work better. 
3) (Good) On the whole, the health care system works pretty well 
and only minor changes are necessary to make it work. 
Time at this point: 
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